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III. Abstract
Galanin is believed to be co-released with acetylcholine by neurones projecting from
the medial septum and nucleus ofMeynert to the hippocampus in rodents. Galanin
inhibits acetylcholine and glutamate release, thereby depressing excess neuronal
excitability in the brain. Although this effect established galanin as an endogenous
neuroprotective substance, released only during high frequency neuronal firing, it
may also explain why it impairs memory and cognition in vivo. The sustained
increase in glutamatergic synaptic strength following high frequency stimulation of
hippocampal neurones, a phenomenon termed long-term potentiation (LTP), has
been widely recognised as a model of the synaptic changes that may underlie
learning and memory in vertebrates. It may thus be predicted that the physiological
action of galanin at the cellular level would be to depress LTP, thereby causing an
impairment in mnemonic processes mediated by the hippocampus. Experiments were
designed to address aspects of this hypothesis, namely: (1) in vitro characterisation of
the effect of galanin agonists and antagonists on synaptic transmission and plasticity
in the CA1 area of rodent hippocampus and (2) investigation of glutamatergic
synaptic plasticity in galanin knockout mice and their wild-type littermates.
Exogenous galanin induced a dose-dependent increase in the slope of baseline
fEPSPs, which appeared to be dependent on the pathways from CA3 to CA1 being
intact, but it did not have any effect on paired-pulse facilitation ratios (PPF) in low
concentration. However, in higher concentration, galanin induced a significant
decrease in PPF in intact slices. In CA3-hemisected hippocampal slices the
aforementioned effects did not occur. The effect of galanin on LTP and long-term
depression (LTD) of glutamate mediated synaptic transmission in apical and basal
dendrites of CA1 pyramidal neurones were investigated using both intracellular and
extracellular recording techniques in vitro. LTP induced in either apical or basal
dendrites of CA1 pyramidal neurones by different paradigms was significantly
inhibited by galanin. Galanin also inhibited LTP in hippocampal slices prepared from
wild-type mice. This effect was reversible by the known galanin antagonist, galantide
(Ml5). Galanin did not affect isolated pure NMDA receptor-mediated postsynaptic
potentials or the loss of spike frequency adaptation and increase in input resistance
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evoked by metabotropic glutamate receptor activation, indicating that its inhibition of
LTP was downstream of these receptors. Galanin applied had no effect the
expression of LTP indicating that galanin may inhibit LTP by interfering with kinase
activity necessary for the induction ofLTP, e.g. protein kinase C. Galanin did not
affect the induction of LTD. Subsequent studies in the galanin-null transgenic mice
yielded no effect on synaptic strength or paired pulse facilitation ratios. Galanin gene
deletion caused a significant impairment ofLTP, which was only observed in basal
dendrites, the magnitude of which increased with age. The underlying molecular
mechanism for this impairment might be a significantly faster saturation of synaptic
plasticity in the mutant mice in vivo, compared to wild-type mice. No effects of
galanin were noted in mutant mice. This could suggest a developmental loss of
galanin-responsive cells concomitant with global galanin gene deletion.
In summary, galanin seems to have a modulatory effect on excitatory
neurotransmitters in the hippocampus, such as glutamate, thereby delaying the
neurodegenerative effect of age. The research described in this thesis is deemed of
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'Men ought to know that from the brain, and from the brain
only, arise our pleasures, our joys, laughter, jests, as well as
sorrows, pains, griefs and tears. Through it, in particular, we
think, see, hear and distinguish the ugly from the beautiful, the
bad from the good, the pleasant from the unpleasant.. .It is the
same thing that makes us mad, or delirious, inspires us with
dread and fear, whether by night or by day, brings
sleeplessness, inopportune mistakes, aimless anxieties, absent -
mindedness, and acts that are contrary to habit. These things
that we suffer all come from the brain, when it is not healthy...'
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CHAPTER 1
GENERAL INTRODUCTION
The aim of this chapter is to present an overview of mechanisms believed to be
involved in the processes of learning acquisition and memory formation, relevant to
key synaptic mechanisms discussed in this thesis. Most of the experimental results
obtained, investigate the role of the neuropeptide galanin on synaptic transmission
and plasticity mechanisms in the hippocampus of rodents. Therefore, the first section
of this chapter is devoted to discussing recent research following the discovery of
galanin. In the second section, the hippocampus and the molecular mechanisms
thought to underlie learning and memory in vertebrates are discussed. The
contribution of the septohippocampal input, with particular reference to the
modulatory role of galanin, is laid out in the context of such hippocampal function.
Chapter 1 concludes with a review of transgenic mouse strains with reference to
resulting alterations in synaptic transmission affecting learning and memory.
1.1. Galanin
Galanin is a neuropeptide widely expressed in brain and peripheral tissues, thereby
exerting a broad range of physiological effects (Kask et al., 1995a-b & 1997). The
neuropeptide was first isolated from porcine intestine as a twenty nine amino acid
neuropeptide in Victor Mutt's laboratory in Karolinska Institute in Stockholm.
Galanin derives its name from its N- and C - terminus residues, glycine and alanine
respectively. It has long been known that many biologically active peptides contain a
C-terminal amidated structure, like, for example, neuropeptide Y. As such, they
make easy targets to proteolytic conversion of their C-terminus amide to the easily
extractable by thin-layer chromatography dansyl derivative. This was how galanin
was isolated from both porcine intestine and brain tissue extracts (Tatemoto et al.,
1983). Following isolation, Victor Mutt's group reported a series of physiological
studies, which established the hyperglycaemic action of galanin in the dog. More
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importantly, however, Tatemoto et al., 1983 suggested the rat ileum preparation as a
suitable pharmacological assay for galanin-like activity.
Molecular biology studies laid down the basis for the production of transgenic mice
in which various manipulations of the galanin gene allow the precise characterization
of galaninergic physiology. Therefore, a review of the studies on the transcriptional
control of the galanin gene is described in paragraph 1.1.1. Moreover, such studies
allowed the delineation of the anatomical distribution of galanin in the CNS of
vertebrates and this is dealt in more detail in section 1.1.2 and Tables 1.1.1. and
1.1.2.
Galanin possesses a highly conserved N - terminal associated with high biological
activity as reported by Lundkvist et al., 1995 and Kakuyama et al., 1997.
Pharmacological studies using peptide analogues such as M35, M32 and C7 have led
to speculation about multiple galanin receptor subtypes being expressed in neural
tissues of vertebrates (Iisma et al., 1999). Since 1994, a total of three G-protein
coupled receptors have been cloned, all of which possess significant homology to the
rhodopsin family of G-proteins including seven predicted hydrophobic membrane-
spanning domains. Expression of at least three different galanin receptor subtypes
appears to be as flexible as the regulation of galanin transcription itself and is
broadly gender- and tissue-specific. Potent, selective antagonists are yet to be
discovered for any of the cloned receptors. A review of galanin receptor subtypes
and their pharmacology is presented in sections 1.1.3. and 1.1.4. respectively.
The link between the known physiological actions of galanin and each of the cloned
receptors and evidence for additional galanin receptor subtypes are issues under
current investigation in this field (Section 1.1.5). More interestingly to this thesis, the
role of galanin in modulating learning and memory in vertebrates is laid out in
section 1.1.6.
1.1.1. The Galanin Gene
Endogenous galanin is synthesised as the pre-pro-hormone pre-pro-galanin, which
comprises a 59 amino acid C-terminal flanking region called Galanin Message
Associated Peptide (GMAP), which has no known function as yet (Rokeaus &
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Brownstein, 1986; Hokfelt et al., 1992). To accomplish the diverse physiological
functions, the transcription of the gene for galanin is highly plastic. Namely,
transcription of the galanin gene is controlled by endogenous hormones and
neuromodulators e.g. oestrogen in the anterior pituitary and NGF in the rat basal
forebrain. Galanin gene transcription also appears to be unpregulated by external
stress factors e.g following denervation and injury in the dorsal root and trigeminal
ganglia. Investigations by Rokeaus et al., 1998 have led to the discovery that bovine
galanin gene induction can be transactivated in human neuroblastoma cells, by
cJun/cFos proteins and the PKC activator phorbol ester PMA. Further genetic studies
indicated that the functional response to galanin gene enhancers or silencers
regulating basal and activity dependent transcription, along with the CRE-like
elements are mapped in the promoter region located upstream the galanin gene
transcription start site. Although the quality and levels of transcriptional control may
vary, the galanin gene promoter region appear to be highly conserved across species
(Wynick et al., 1998a-b).
1.1.2. Anatomical Distribution of Galanin
The isolation and synthesis of galanin allowed the development of antibodies
towards different parts of the galanin molecule, which have been used to map the
distribution of galanin-like immunoreactivity by immunocytochemical methods and
to measure the content of galanin protein and mRNA content in several tissue
extracts by radioimmunoassay, in situ hybridisation and immunocytochemistry,
respectively. Tables 1.1.1. and 1.1.2 summarise the results of the above studies.
Galaninergic cell bodies and fibre systems are present in the central nervous system
in varying degrees. Notable is the presence of galanin-like immunoreactivity in the
cell bodies of septal nuclei and in the fimbria of the hippocampus in the rat. A similar
distribution has been observed in the monkey and it is summarised in Table 1.1.2
(Melander et al., 1986 a-b & 1987; Langel et al., 1992; Chang et al., 1995).
Interestingly, galanin has been found to coexist with some of the classical
neurotransmitters such as acetycholine, glutamate, noradrenaline and serotonin
(Crawley & Wenk, 1989; Hokfelt et al., 1998, 1999).
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Area Human Monkey Pig Rat Mouse





























Genital tract IH/RIA IH/RI
A
Table 1.1.1. Anatomical distribution of galanin-like immunoreactivity measured in
different areas using immunohistochemistry (IH), radioimmunoactivity (RIA) and
in situ hibridisation studies (ISH) (Skofitch et al., 1986 a-b; Bartfai et ah, 1993).
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Medial Septal Nucleus +++ +++





















Arcuate nucleus +++ ++
Locus coeruleus ++
Nucleus of the solitary tract +
Caudal spinal trigeminal
nucleus ++ ++
Fimbria of the hippocampus + ++
Pituitary gland +
Dorsal horn of the spinal
cord
+
Table 1.1.2. Galanin-positive cell body and fibre system distribution in the monkey
brain (Melander et al., 1985 and 1986a-c; Crawley and Wenk, 1989).
1.1.3. Distribution of Galanin Receptor Subtypes
Table 1.1.3. summarises the anatomical distribution of galanin receptor subtypes.
GALR1
The human galanin receptor type 1 (GALR1) was isolated by the human Bowes
melanoma cell line and other sources. GALR1 contains 349 amino acids with the
structure of a G-protein coupled receptor (Habert-Ortoli et al., 1994). In amino acid
composition GALR1 is most similar to rat GALR1, GALR2 and GALR3, while it
retains some homology to human receptors activated by peptides like somatostatin
and opioids (Lee et al., 1999). Rat GALR1 was cloned from brain cells and shares
the same consensus sequences for N-glycosylation and intracellular phopshorylation
with the exception of two additional phospshorylation sites in the human GALR1 C-
terminal domain. The mouse GALR1 was mapped to chromosome 18, which
coincides with the human gene position. The distribution of GALR1 is particularly
prominent in the human fetal brain and gastro-intestinal tract. In the rat, GALR1 is
most prominently expressed in the brain and spinal cord. The pattern of rat GAL1
receptor expression shows variability, for example gall mRNA is elevated in females
compared to males and varies during the estrous cycle (Faure-Virelizier et al., 1998).
• • •• • 19 S •
Human and rat GAL1 receptors share similar binding profiles in [ I] galanin
binding assays (Wang et al., 1998a). The salient physiological actions resulting from
the activation of GAL1 receptor include the inhibition of neurotransmitter or
hormone release in many brain regions with potential to modify memory, feeding,
emotion, nociception, gut secretion and motility, glucose/insulin homeostasis and
human growth and development (Bartfai et al., 1993). In agreement with the latter
role, children with a growth hormone insufficiency phenotype display a common
deletion of two megabases from chromosome 18, which results in the absence of the
GALR1 (Cody etal., 1997).
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GALR2
Originally cloned from the rat, GALR2 is thought to be a G-protein coupled protein
consisting of 372 amino acids including consensus sequences for glycosylation and
intracellular phosphorylation sites distinct from GALR1 (Smith et al., 1997b). The
human GALR2 protein contains 387 amino acids and both rat and human receptors
have been mapped to chromosome 17, while the mouse GALR2 maps to
chromosome 11 (Pang et al., 1998; Fathi et al., 1998). Preliminary investigations,
using RNAase protection, support the idea that GALR2 may be expressed instead of
GALR1 in some tissues. For example, in the rat anterior pituitary, GALR2 but no
GALR1 is expressed, suggesting that GALR2 receptor may mediate the effects of
galanin on pituitary hormone secretion (Fathi et al., 1997). However, there appears to
exist confusion between reports as to the distribution of human gal2 mRNA in the
brain (Fathi et al., 1997).
The widespread distribution of rat gal2 mRNA suggests numerous physiological
consequences of GALR2 signalling, including prolactin release, lactation, growth
hormone release, feeding, emotion, memory, nociception, cellular growth, nerve
regeneration, pancreatic islet function, cardiovascular tone, peripheral metabolism
and reproduction (Smith etal., 1997a-b; Howard etal., 1997;Wang et al., 1997a-b;
Fathi et al., 1997).
Interestingly, the gene encoding human GALR2 is associated with two human
diseases, hereditary neuralgic amyotrophy and Russel-Silver syndrome, which are
characterised in part by short stature, and low birth weight dwarfism respectively, in
addition to other developmental defects (Fathi et al., 1998). Galanin null mice, on the
other hand, do not seem to suffer from such abnormalities (Wynick et al., 1998b).
Relevant to this thesis is the possible role of galanin receptors in diseases of the
nervous system. In this respect, it has been shown that in dementia of the
Alzheimer's type (AD) galanin containing fibres hyperinnervate acetylcholine
containing neurones of the basal forebrain, prompting speculation that a receptor
such as GALR2 might function to promote survival of the ageing population of
acetylcholine neurones (Chan-Palay et al., 1988). Consistent with the above concept,
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it has been shown that in models of experimental injury galanin and gal2 mRNA
levels are upregulated, leaving open the possibility that GALR2 may have a dual role
as a survival mediator and autoreceptor (Sten-Shi et al., 1999).
GALR3
The GALR3 was originally cloned from the rat and exists as a protein of 370
residues. GALR3 amino acid composition bears most similarity to the rat GALR2
(Lee et al., 1999; Smith et al., 1998a-b). Human GALR3 was cloned from a human
genomic library based on the structural similarity to human GALR1 and GALR2
proteins (Kolakowski et al., 1998). Human GALR3 contains 368 amino acids and
exhibits 90% similarity to rat GALR3. They both contain a single consensus
sequence for N-glycosylation and multiple intracecellular consensus sites for
phosphorylation, the most distinct of which is the C-terminus PKC phosphorylation
site. The human and rat GALR3 was mapped to chromosome 22, while the mouse
GALR3 was cloned and mapped to chromosome 15 (Kolakowski et al., 1998).
Possible effects mediated by GALR3 activation, based on its distribution pattern,
include emotion, feeding, pituitary hormone release, nociception and metabolism.
The distribution of GALR3 mRNA is widespread in rat, mouse and human in both
neural and peripheral tissues as shown in Table 1.1.1.
The three galanin receptor proteins share 83 conserved amino acids and although
they are similar to somatostatin receptors (types 4 and 5) and to a nociceptin receptor
(ORL1), they form a distinct receptor superfamily.
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Table 1.1.3. The distribution of expression of the three galanin receptor subtypes (Mufson et al.,
1998; Kolakowski et al., 1998;Wang et al., 1998a; Iisma et al., 1999).
Receptor Isolated/ Method Distribution Coupling Physiological
Cloned Effect
from
Human Bowes northern blot foetal brain •I cAMP growth &
GAL1 melanoma RT-PCR GI tract Tk+ development
cell line channels glucose/
Rat GAL1 brain northern blot hypothalamus T MAP insulin
RIN-14b ish amygdala Kinase homeostasis






Rat GAL2 RNAase Rat cDNA brain & T PLC Pituitary
protection peripheral tissues Tip hormone
ISH apart from the T Ca2^ secretion in rat












GAL3 Human Nothern blot Heart Tk+ glucose/insulin
genomic RNAase spleen channels homeostasis in








1.1.4. Pharmacology of Galanin Receptors
All three galanin receptors possess high affinity for full length and N-terminal
fragments of galanin and for chimeric peptides containing the N-terminus from
galanin (Smith et al., 1997b; Wang et al., 1997c-e). The structure of galanin
analogues is presented in Figure 1.1.^4. GALR1 and GALR2 receptors share similar
pharmacological profiles, while the pharmacology of GALR3 combines the profiles
of GALR1 and GALR2 (Figure 1.1.i?). Human and rat GALR2 appear to share
common pharmacological profiles as well (Wang et al., 1997c).
Endogenous Ligands
Structure-activity studies on the galanin peptide demonstrated that the N-terminal 1-
16 amino acids are conserved across species and that this peptide fragment is
sufficient for receptor recognition (Fisone et al., 1989a). The 17-29 C-terminal
fragment is not recognised by hypothalamic, hippocampal, spinal cord and pancreatic
receptors and seems to bare no biological effect. Nevertheless, this fragment appears
to be required for galanin binding to receptors in smooth muscle, different subtype to
neuronal and exocrine tissue (Rossowski et al., 1990). Galanin 1-12 is the shortest
form of galanin demonstrating full receptor agonism, but the C-terminal portions of
the galanin 1029 polypeptide are arranged by beta helix to protect the peptide
configuration from proteolytic cleavage and for receptor subtype recognition. Human
galanin is a 30 amino acid long peptide with a free carboxy-terminus because the
amide donor glycine present in all other species is replaced by serine (See Figure
1.1). Various other ligands apparent in many anatomical areas of the brain and
exerting their effect on varied physiological responses have been reported to act
through multiple receptor subtypes and/or second messenger systems (Branchek et
al., 2000). Evidence for multiple receptor subtypes in native brain tissue comes from
both radioligand and functional studies. For example, galanin binding sites with a 10-
fold difference in affinity for galanin and galanin 1-16 have been reported in the rat
hippocampus (Fisone et al., 1989b). Also there is evidence for an N-terminal
preferring receptor in the rat dorsal hippocampus, neocortex and neostriatum
(Hedlund et al., 1992). Porcine, rat and human endogenous galanin peptides are laid
out in the top panel of Figure 1.1 A.
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Exogenous Ligands
The NH2 terminal fragments 1-12,1-15, and 1-16 behave like high affinity agonists to
galanin binding sites in the brain in both in vivo and in vitro experiments. Peptide
fragment experiments have shown that for hippocampal galanin receptors the NH2
terminal 1-12 amino acids are sufficient for ligand recognition (Langel & Bartfai.,
1998). Another approach to using truncated peptides containing the amino acid
sequence necessary and sufficient for galanin receptor recognition has been the
design of high affinity chimeric peptides, that share the NH2 terminal 1-13 amino
acids with galanin and have different sequences covalently attached to the carboxy
group of proline 13, like for example, M15, galanin-l-13-neuropeptide Y (M32),
galanin-l-13-bradykinin-2-9 amide (M35), galanin-13-Pro-Ala-Leu-Ala-Leu-Ala
amide (M40) and galanin-l-13-spantide amide (C7). Although these compounds
appear to act as antagonists to the effects of exogenous galanin application in
physiological experiments, like, for example, in the hippocampus and hypothalamus
(Kask et al., 1995; Jureus et al., 1997), they act as partial agonists in transfected cell
lines expressing 5-500 fold more galanin receptor sites per cell than in vivo (Smith et
al., 1997b). Their structure is laid out in Figure 1.1.5. Recently, small, non-peptide
ligands to galanin receptors have been discovered which bind to cloned human




The coupling mechanisms of the three galanin receptors are summarized in Table
1.1.3.
Cloned GAL1 receptor activation leads to a reduction in the intracellular
concentration of cAMP, opening of G-protein coupled inwardly rectifying K+
channels and the pertussis toxin sensitive stimulation of MAP kinase activity (Wang
et al., 1998a); this is consistent with coupling to G;/0-type G-proteins (Habert-Ortoli
et al., 1994; Parker et al., 1995; Burgevin et ah, 1995). Upon agonist binding, cloned
GALR1 receptors, expressed in CHO cells, mediated a reduction of forskolin-
stimulated cAMP (Parker et al., 1995; Burgevin et al., 1995). This reduction of
cAMP was blocked by pertussis toxin (Parker et al., 1995; Smith et al., 1997b)
supporting the involvement of Gi/0-type G-proteins. Also, it has been reported that
GALR1 activated an inwardly rectifying K+ current when GIRKs 1 and 4 were
cotransfected into Xenopus oocytes (Smith et al., 1998a). Taken together, it appears
likely that GALR1 may act broadly to inhibit neurotransmitter/hormone release.
Activation of GALR2 leads to the stimulation of multiple intracellular events, most
ofwhich result from the activation of phospholipase C. This finding is consistent
with reports of GALR2 mediating pertussis toxin resistant inositol phosphate
hydrolysis, intracellular Ca2+ mobilisation and Ca2+ dependent CI" channel opening
(Smith et al., 1997b). Additionally, GALR2 may activate other intracellular
pathways depending on the host cell and/or the G-protein mixture in the cell and the
species homologue of the receptor (Wang et al., 1997a-d & 1998f). Although
functional studies support the existence of native galanin receptors positively
coupled to inositol phosphate hydrolysis, a native receptor with a well defined
GALR2-like pharmacology has not yet been described. Human and rat GALR3
proteins share many pharmacological profiles in [125I] binding assays and they both
mediate a pertussis toxin-sensitive activation of an inward rectifying K current in
Xenopus oocytes, which is consistent with them acting on Gj/0 proteins. GALR2
activation appears to produce a variety of cellular responses such as pertussis toxin-
resistant inositol phospholipid hydrolysis, calcium mobilisation (Smith et al., 1997)
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in CHO cells as well as activating Ca2+-dependent CI" channels in Xenopus oocytes.
GALR2 activation did not inhibit forskolin-stimulated cAMP (Smith et al., 1997b) in
CHO cells which, taken together, suggest a primary coupling to G-proteins Gq/n
activating phospholipase C.
A native cell line or tissue model with a distinctive GALR3 pharmacology has not
yet been described, but GALR3 activation leads to a hyperpolarising current
consistent with a role in secretion e.g. glucose/insulin homeostasis in the pancreas.
The complex binding and functional profiles for galanin and other galanin peptides
such as M32, M35 and C7 with a spectrum of antagonist/agonist activity are
consistent with the existence of multiple receptor subtypes. Native galanin receptors
have been reported to activate several second messenger pathways resulting in
numerous cellular responses. Some examples include the inhibition of cAMP
production (Amiranoff et al., 1991), inhibition of L-type and N-type voltage-gated
Ca2+ channels (Palazzi et al, 1991; Kalkbrenner et al., 1995); the activation of ATP-
sensitive K+ channels (Dunne et al., 1989) and inwardly rectifying K+ channels such
as GIRK-1 (Philipson et al., 1995), as well as the stimulation of phosphoinositol
breakdown, calcium mobilisation (Sethy & Rozengurt, 1991), phospholipase A2
(Mulvaney & Parsons, 1995) and MAP kinase (Seufferlein & Rozengurt, 1996).
It is clear that there exists a complexity of physiological responses to galanin binding
but also differences in the functional pharmacology of such responses. Galanin
reduced forskolin-stimulated cAMP with 250-fold greater potency in rat ventral
hippocampus versus dorsal hippocampus suggesting either receptor diversity or
differences in signal transduction pathways (Valkna et al., 1995). Other possible
explanations could be differences in the number of functioning receptors or the
efficiency of receptor/effector coupling in the different regions of the hippocampus.
Both rat and human GALR3 share a unique consensus phosphorylation site in the
third intracellular loop that may be implicated in G-protein-coupling and receptor
function. GALR3 activation in Xenopus oocytes open GIRKs in response to applied
galanin (Smith et al., 1998). This effect was blocked by pertussis toxin suggesting























Human Rat Human Rat Human Rat
P orcine G alanin 9.63 9.49 9.02 8.98 8.0 1 8.14
R at Galanin 9.54 9.47 8.79 8.87 7.91 8.48
Hum an G alanin 9.36 9.22 8.63 8.60 7.16 7.28
M 1 5 9.61 9.19 8.97 9.00 7.40 7.98
M 32 9.58 9.17 8.84 9.10 8.22 8.91
M 35 9.95 9.49 8.71 8.49 7.84 8.68
M 40 8.62 8.17 8.39 8.45 6.54 7.10
C 7 9.58 9.55 9.20 9.25 8.09 7.98
Figure 1.1. Galanin receptor ligands and pharmacology. A, Peptide analogues used to
characterise galanin receptor pharmacology. All galanin homologues shown are conserved in
residues 1-14. Human galanin contains 30 amino acids rather than 29 and in terminating with a
C-terminal free acid(*) rather than an amide. The chimeric peptides share a common motif in
which the biologically active N-terminal region of galanin -1-13 is conserved (adapted from
Branchek et al., 2000). B, Radioligand binding displacement profile of [125I]Galanin from rat
and human GALR1, GALR2 and GALR3 (pKj values taken from Smith et al, 1998).
1.1.5. The Neuromodulatory Effect of Galanin
The physiological effects of galanin have been studied extensively in experimental
paradigms which include gut secretion and motility, cardiovascular and
cerebrovascular tone, feeding behaviour, neuroendocrine regulation (Roassmanith et
al., 1996), lactation and reproduction, pain (Palkovits et al., 1995), neuroregeneration
(Kask et al., 1997), depression and the modulation of acetylcholine release, memory
and Alzheimer's disease (McDonald et al., 1997). All the galanin ligands mentioned
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in this section are discussed in more detail in section 1.1.4. and Figure 1.1.
Additionally, their lull, published names are mentioned in the Abbreviations section.
On the cellular level, galanin has been shown to affect motility of smooth muscle and
neurotransmitter release, e.g. of insulin, somatostatin, VIP, NO and glutamate
(Schmidt et al., 1991; Zini et al., 1993; Niiro et al., 1998; Wang et al., 1998g). As
such, the physiological functions of galanin, linked to cognitive and behavioural
deficits, include the inhibition of glutamic acid release, the decrease of spinal
neurone excitability and the blockade of voltage activated calcium channels. Human
endogenous galanin is co-localised with acetylcholine in cholinergic terminals,
thereby inhibiting its release in a number of central areas including the basal
forebrain Nucleus Basalis of Meynert and stria terminalis (Chan-Pallay et al., 1988;
Melander et al., 1989; Mufson et al., 1993 & 1998; Crawley, 1993 & 1996; Bowser
et al., 1997; McDonald et al., 1997), striatum (Sebok et al., 1996), nucleus solitarius
(Maley, 1996) and tegmental nucleus (Gai et al., 1993). Porcine galanin inhibits
neurotransmitter release, inhibits secretion of somatostatin, insulin and pancreatic
polypeptide and blocks voltage-gated calcium channels (Haynes, 1986; Tatemoto et
al., 1983). Rat galanin inhibits neurotransmitter release, blocks voltage-sensitive
calcium channels.
Galanin and Feeding
Intraventricular injection of galanin stimulates food intake in rats, an effect that can
be reversed by C7 and M40 (Corwin et al., 1993). Although all receptors for galanin
are present in brain regions important in feeding, only gall mRNA is upregulated by
glucose and fat metabolism inhibitors (Faure-Virelizier et al., 1998). As such, it
seems likely that feeding may be influenced by GALR1 or an unknown galanin
receptor subtype rather than GALR2 or GALR3 peptides.
Galanin and Pain
Galanin has been studied in many experimental models of pain. In the rat flexor
reflex model, which is a measure of motor response to nociceptive stimuli, galanin
applied intrathecally facilitates the nociceptive reflex at a low dose, but inhibits it at a
high dose (Wiesenefeld-Hallin et al., 1989). The effect is blocked by C35 and M32,
while M40 is a partial agonist. In the tail flick and Randall-Selitto tests, intrathecal
15
application of galanin potentiates the effect of morphine-induced analgesia, while
M35 and Ml 5 produce the opposite effect (Reimann et al., 1994).
In all pain models the antagonist behaviour in vivo does not agree with their action
on cloned receptors. A role for GALR1 in the nociceptive reflex pathway was
suggested after it was shown that intrathecal administration of a cell-penetrating
peptide nucleic acid (DNA) complementary to GALR1 blocked the inhibitory effect
of galanin on the flexor reflex in the rat (Wynick et al., 1998a), but the effect on the
chimeric peptides such as M40 and C7 was not reported. Interestingly, after sciatic
nerve transection galanin and galanin message associated peptide undergo a long
lasting upregulation in dorsal root ganglia. In transgenic mice lacking galanin there is
a loss of galanin containing fibres in dorsal root ganglia and, a defective rate of nerve
regeneration and the absence of autonomy after sciatic nerve cut, in addition to
defects in prolactin secretion and lactotroph function. The aforementioned studies
suggest that galanin receptors might be active in hyperalgesic states such as
neuropathological pain. However, the roles of the individual receptors have yet to be
characterized in detail.
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1.1.6. Galanin impairs learning and memory
Intraventricular or intrahippocampal infusion of galanin in rats impairs performance
in various learning and memory tasks. An example is the delayed non-matching to
position task, in which the effect was reversed by M40 (McDonald et ah, 1996).
These observations coupled with the finding that galanin may inhibit acetylcholine
release have led to the speculation that a galanin antagonist might enhance cognition
(Fisone et al., 1987). Further interest in galanin and cognition has been sparked by
the observation that galaninergic fibres hyperinnervate to nurture the rapidly
decaying cholinergic neurones in Alzheimer's disease (Ogren et al., 1996 & 1998).
In a recent study, a combination of the galanin antagonist M35 and the Ml
muscarinic receptor agonist TZTP has been shown to improve performance in the
delayed non-matching to position task in rats whose performance is compromised by
forebrain lesions (McDonald et al., 1998).
It is clear that there is a lack of profile concordance for cloned galanin receptor
subtypes with their effects in native systems. The cloned receptors do not readily
account for the reported antagonist actions of the chimeric peptides Ml 5, M32, M35,
M40 and CI.These apparent discrepancies could be explained by the presence of
further unknown galanin receptor subtypes awaiting discovery. Moreover, it might
be that peptide tools used for evaluating these receptors are biologically or
chemically unstable at the time of the experiment. Finally, it might be that the lack of
detectable antagonist activity in the heterologous expression systems is artefactual as
a result of high receptor reserve.
Other ways to elucidate the role of galanin, apart from pharmacological studies,
include antisense techniques, orphan receptor characterisation and continued cloning
efforts as well as the use of transgenic animals.
Anatomy of the Galanin Colocalisation with Acetylcholine
As mentioned above, galanin has been localised with and shown to modulate
cholinergic transmission in the gastrointestinal tract and hippocampus in rodents and
other vertebrates (Larson et al., 1990; Talmage et al., 1992; Bennett et ah, 1991;
Herzig et al., 1993; Degli-Uberti et ah, 1996; Ferris et al., 1999). Galanin colocalises
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to 30-35% ChAT positive neurones in the medial septum and diagonal band in the rat
(Melander et al., 1985 and 1986a) and mouse. To a great extent these galanin
positive neurones project to fibre terminals in the hippocampus (Melander et al.,
1986a; Gaykema et al., 1991), as shown in Table 1.1.2. In primates, however,
Galanin does not coexist with acetylcholine. Instead, numerous galaninergic
interneurones are localised near the cholinergic neurones (Gentleman et al., 1989;
Benzing et al., 1993; Mufson et al., 1993). In senile dementia of the Alzheimer's
type (AD), these galaninergic interneurones hyperinnervate the decaying cholinergic
cell bodies. The axons of the galanin positive neurones are enlarged and show
varicosities embracing the cholinergic neurones and dendrites. The increase in
galanin expression appears to correlate with the severity of the disease (Chan-Palay
et al., 1998; Mufson etal., 1993).
Galanin affects Behaviour by modulating Ach release
Structural findings have led to a number of physiological studies addressing the role
of galanin in the modulation of the cholinergic system including its effects on
acetylcholine (ACh) release, learning and memory.
Acute, intrahippocampal administration ofgalanin to target the third ventricle of
rodents inhibits scopolamine induced ACh release in a dose-dependent manner and is
reversed by co-administration of galanin receptor antagonists Ml 5 and M40 (Verge
etal., 1993; Yu, J. etal., 1997). Centrally administered galanin also has inhibitory
effects on several tests of learning and memory such as the Morris water maze and
those involving conditioning (McDonald et al., 1997; Mastropaolo et al., 1988).
These effects are reversed by the antagonist M40. In contrast to these inhibitory
actions, Crawley (1996) demonstrated that exogenous galanin has no effect on the
increased release of ACh that occurs when a rodent is exposed to a novel
environment. Neither of the galanin antagonists have an effect on ACh release or on
cognition, in the absence of exogenously administered galanin. Similarly, Sakurai et
al. (1996) have shown that while exogenous galanin inhibits LTP in vitro, M40 has
no effect on LTP when applied on its own. However, it is becoming more and more
apparent that Ml 5 and M40 ligands may act as partial agonists in some tissues and as
full agonists in vitro to cloned galanin receptor subtypes (Yu et al., 1997; Gu et al.,
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1993). Despite the conflicting data, which point to the limitations of existing
pharmacological tools in this field, it is possible and quite likely that endogenous
galanin may still be released in vivo during high frequency firing to regulate ACh
release during plasticity, injury or anoxic damage.
The Galanin-Null Mouse
The way galanin null mice were generated is described in more detail in section
2.1.3. The electrophysiological analysis of the galanin-null mice and their wild-type
littermates are dealt with in Chapter 5. To date, there is little evidence to support the
role of galanin on cell survival, and neuromodulation of the rapidly decaying
cholinergic neuronal population in basal forebrain during dementia. However, the
importance of galanin on cell survival and regeneration of sensory neurones
following injury was discovered by Wynick et al. (1998a). Moreover, the role of
galanin as a growth factor to the prolacting secreting cells of the pituitary gland has
been well documented (Hammond et al., 1996). While in vitro techniques and cell
lines have an important place in integrated studies of biological systems, homeostatic
mechanisms are best studied within the intact organism. The generation of transgenic
animals may provide a bridge between molecular and physiological studies
investigating the role of galanin in the intact organism, but would shed light on the
action of galanin in learning and memory. Wynick et al., (1998b) have generated a
mutant mouse lacking a functional galanin gene (a galanin knockout mouse), the
analysis ofwhich has allowed the function of galanin to be studied in a manner not
previously possible.
The absence of galanin had a marked degradatory effect on prolactin message levels
and protein content, both in the pituitary and serum rendering mutant female mice
unable to lactate. However, no effect was observed in the pituitary content of GH,
TSH, LH and FSH or the hypothalamic content ofNPY and glucagon-like peptide-1,
peptides involved in the growth and food intake, respectively. The foregoing data
provide supporting evidence for the role of galanin as a survival factor to the
lactotroph and added to the observations that galanin mutant animals show a long-




The earliest reference to the human brain is found in a recovered ancient Egyptian
papyrus written in 17th century B.C. and it described the prognosis of head injury.
However, written proof on the debates concerning the function of the brain are
attributed to the Greek philosophers at 400 B.C. Hippocrates believed that the brain
was the seat of consciousness whilst Aristotle opposed this view. Instead, he held
that intellectual, perceptual and related functions originated from the heart. Again,
Hippocrates was drawing his estute conclusions from observation of patients with
neurological disorders, like epilepsy, or head injuries. However, the physiology of
the brain remained unexplored and it was not until the nineteenth century that the
concept of "functional localisation" was developed by Paul Broca. Since then, the
trend has been to describe the brain in ever-smaller functional units. This concept
was initially based on the rationale that anatomical segregation confers distinct
functions (Finger, 1994).
The hippocampus has proven a challenging area to investigate on both counts: its
distinctive shape (in Greek hippos means 'horse' and campos 'sea monster') and
readily identifiable, laminated structure and its fundamental role in certain aspects of
learning and memory. The hippocampus is of high interest in biomedical research
because it is one of the most susceptible areas affected by pathological conditions,
such as epilepsy, ischaemia and anoxia, senile dementia and especially AD. Evidence
linking the hippocampus with a role in memory and learning commence as early as
1887, when it was shown that damage to the temporal lobes and the underlying
hippocampus in monkeys produced deficits in memory formation and retention
(Brown & Schafer, 1888). Twelve years later, Bechterew described a memory deficit
in a patient who, upon autopic examination, displayed bilateral softening of the
hippocampus and adjoining temporal cortex. However, it was not until 1953 that
interest in the hippocampus was renewed when case H.M. underwent neurosurgery to
alleviate the symptoms of his severe epilepsy by bilateral removal of parts of the
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temporal lobe. After aspiration of the hippocampus and a number of associated brain
areas, the patient displayed profound anterograde declarative memory loss as well as
some retrograde amnesia extending back several years (Scoville, 1954; Scoville &
Milner, 1957). Non-declarative or procedural memory tasks, such as learning a motor
skill, were unaffected and, therefore, this cognitive process was believed not to be
dependent on the hippocampus. These findings led to a plethora of experimental
lesion studies conducted mainly on primates and rodents, which confirmed a role for
the hippocampus in certain types of memory formation.
1.2.2. Anatomical Structure of the Rodent Hippocampus
The hippocampal formation comprises four cortical regions including the dentate
gyrus, the hippocampus proper (divided into the CA1, CA2 and CA3 subfields, the
latter two subfields sharing many connectional characteristics), the subicular
complex and the entorhinal cortex. The three dimensional shape of the hippocampal
formation appears grossly as an elongated structure with its septotemporal (long)
axis, bending in a C-shaped manner from the septal nuclei rostro-dorsally to the
temporal lobe caudo-laterally (Figure 1.2.A). In the perpendicular transverse
(orthogonal) section (Figure 1.2 .B) the principal pathways can be viewed and have
been determined in classical Golgi studies (Lorento deNo, 1933 & 1934) and
degeneration studies. These studies showed the dentate gyrus receiving its major
input from the perforant path of the entorhinal cortex. The granule cells of the
dentate gyrus, in turn, project mossy fibres that terminate on the dendrites of the CA3
pyramidal cells. These cells project collateralised afferents that terminate within the
CA3 region as associational connections and provide the major input to the CA1
field of the hippocampus, termed the Schaffer collaterals. The majority of these
afferents synapse within the apical dendritic field of the CA1 pyramidal cells in the









Figure 1.2 The Hippocampus
A shows a schematic representation of the rat brain and the position of the left hippocampus
within it. B illustrates a schematic representation of the transverse hippocampal slice in which
the main areas (area CA1, area CA3, dentate gyrus, subiculum and fimbria) are marked. Note
the different scales in the two figures.
Per Andersen and coworkers suggested a lamellar organisation of these pathways,
splitting the hippocampus into functional 'strips' that are stacked along the
septotemporal axis (1964, 1969 and 1971). It has subsequently been shown that,
besides the mossy fibre projection from the dentate gyrus, the hippocampal
projections are as extensive and highly organised in the septotemporal axis of the
hippocampus as in the transverse axis (Amaral and Witter, 1989).
The principal cells of the hippocampus are CA1 and CA3 pyramidal glutamatergic
cells. Glutamate receptor density is high throughout the structure with
autoradiography ofNMDA receptor binding highest at the zones connecting granule
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cell dendrites and CA1 pyramidal cell dendrites. In addition to the principal cells of
the hippocampus, there exist a variety of intrinsic GABAergic interneurons that form
extensive connections with the pyramidal and granule cells. In conjunction with
inhibition provided by pyramidal cell recurrent collaterals, the GABAergic
interneurons generate the IPSP component of the pyramidal cell response by
feedforward inhibition. This is discussed in greater detail in section 1.2.4.
There are also extrinsic inputs into the hippocampus that utilise different
neurotransmitters to exert their effect, including serotonergic afferents from the
dorsal raphe nucleus, nor-adrenergic afferents from the locus coeruleus and a
heterogeneous population of afferents arising from the medial septum/diagonal band
complex of the basal forebrain (Swanson et al., 1982). These latter connections
consist of GABAergic, peptidergic (in particular, galaninergic afferents) and
cholinergic fibres. The cholinergic pathway has been extensively implicated in
memory and learning related behaviour and is discussed in section 1.3.
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1.2.3. The Hippocampal Slice
Andersen's idea was influential leading to the development of the transverse
hippocampal brain slice preparation introduced in 1971 (Skrede et al., 1971). Most
electrophysiological experiments performed on the hippocampus exploit the slice cut
at right angles to the orthogonal axis of the hippocampal formation (transverse slice)
thus severing the septotemporal connections. As the experimental work within this
thesis is performed on transverse slices, the connections and synapses of the
transverse hippocampal orientation will be focused upon. For a review on the
anatomy of the hippocampus and its principal connections see Amaral & Witter
(1989).
A striking feature of the hippocampus is that it is essentially laminar, each layer
containing the same circuitry. Therefore, a thin e.g. 150 - 350 pm hippocampal slice
contains all components and appropriately connected associations, so it is thought to
be a valid substitute for the whole structure and the regularity of the circuitry
facilitates attempts at functional modeling (Suter, Smith & Dudek, 1999).
Consequently, the transverse hippocampal slice has proven extremely popular in
investigations of excitatory synaptic transmission due to the conservation of the
trisynaptic circuitry (see Figure 1.4 overleaf) and the clear morphological visibility
of the different fields that comprise the hippocampus (Yamamoto & Mcllwain, 1966;
Skrede & Westgaard, 1971; Andersen, 1981). This preparation allows the recording
of electrophysiological activity from single cells or populations of cells in a
controlled extracellular milieu. Although interpretation of such data and its relation
to in vivo activity is subject to constraints due to the gross severance of convergent
extrinsic inputs and intrinsic septotemporal connections, recordings may be more
stable and longer lasting than during an in vivo experiment. A great advantage in
using hippocampal slices for studying excitatory synaptic transmission is that animal
anaesthesia becomes obsolete. Additional methods to visualize neurons have been
devised e.g. intracellular staining with biocytin, lucifer yellow or Nissl staining
(Figure 1.3).
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Figure 1.3. A Nissl-stained section of the hippocampal slice.
Figure 1.4. Synaptic circuitry of the rat hippocampal slice
A schematic representation of the hippocampal slice illustrating the major excitatory pathways
which comprise the trisynaptic circuit. The direction of synaptic connectivity between pathways
is: perforant path -> mossy fibres -> Schaffer collateral-commissural fibres. Note the clear
differentiation between laminae (s. oriens, s. pyramidale and s. radiatum).
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1.2.4. Synaptic Transmission in the Schaffer-Collateral Commissural Pathway
During low frequency (<0.1 Hz) stimulation of the Schaffer-collaterals, the evoked
response observed in CA1 pyramidal neurons comprises a fast EPSP rapidly
curtailed by a biphasic IPSP (Kandel et ah, 1961; Alger & Nicoll, 1982b). The EPSP
is believed to be mediated by AMPA receptors (EPSPa) (Davies & Collingridge,
1989) whilst the biphasic IPSP is mediated by GABAa (IPSPa) (Schwartzkroin &
Prince, 1980; Alger & Nicoll, 1982a) and GABAb (IPSPb) receptors (Dutar &
Nicoll, 1988c; Soltesz et al., 1988; Lambert etal., 1989). Under a variety of
conditions, e.g. reduced presynaptic inhibition (Wigstrom etal., 1986b), both
EPSPaS and EPSPns can be evoked. In each case it is believed that it is the release of
L-glutamate from presynaptic terminals that accounts for each response.
Originally, it was thought that the IPSP component of the evoked response was
solely caused by recurrent (feedback) inhibition (Kandel et ah, 1961; Andersen et ah,
1964). However, it was realised that a feedforward inhibitory circuit was also
responsible for the IPSP (Alger & Nicoll, 1982b; Scwartzkroin et ah, 1983; Buzsaki,
1984b). Accordingly, activation of AMPA and NMDA receptors on GABAergic
interneurons were shown to result in the IPSPs observed in CA1 pyramidal neurons
(Sah etal., 1990).
The classic, fast hyperpolarising IPSPa, evoked by both recurrent and feedforward
circuits, was characterised by its sensitivity to bicuculline and to changes in both
intracellular and extracellular CI" concentrations (Kandel et ah, 1961; Andersen et
ah, 1964; Allen et al., 1977; Dingledine & Gjerstad, 1980). Feedforward inhibitory
circuits also activate a GABAb receptor-mediated slow IPSPb , which was originally
characterised by its similarity to (-)-baclofen-induced hyperpolarisations (i.e. both
exhibited similar I-V relationships and dependency on extracellular K+) and was
subsequently confirmed by the inhibition of IPSPbs using selective GABAb receptor
antagonists (Lambert et ah, 1989).
Table 1.2.1. shows the principal receptor systems and Figure 1.5 is a schematic
representation of the known inhibitory and excitatory receptor systems involved in
synaptic transmission and plasticity in the rodent hippocampus.
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Table 1.2.1. The principal receptor systems involved in hippocampal synaptic transmission and
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Figure 1.5. Schematic representation of the molecular mechanisms of the principal excitatory
and inhibitory receptor systems involved in synaptic transmission and plasticity at the en
passage synapses of the Schaffer collateral comissural pathway with CA1 apical and basal
dendrites (picture obtained from F. Duprat with permission but based on research discussed in
Collingridge and Bliss, 1993 and Bortolotto et aU, 1999).
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1.2.5. Synaptic Plasticity
When the Spanish anatomist Ramon y Cajal gave the Croonian Lecture to the Royal
Society in London in 1894, he advocated that the physiological basis of memory lay
in the alterations of neuronal connectivity. He put forward the idea that the likely
site, where activity of neuronal circuits could encode memory traces, might be
between adjacent neurones, the synapses.
Fifty years on, Konorski (1948, summarised in Konorski, 1967) and Hebb (1949)
each suggested rules by which these synaptic changes might occur. The timescale
and extent of these changes are variable ranging from the permanent gain or loss of
synapses to transient fluctuations in the strength of individual synapses, thereby
altering the efficacy with which they may interact with the postsynaptic cell. Hebb's
rule published in 'The Organisation of Behaviour' in 1949 states that if two neurones
are excited at the same time, then any active synapses between them will be
strengthened. Hence, Hebbian synapses act as coincidence detectors, equipped to
monitor the degree of correlation between firing of pre- and postsynaptic neurones.
As such, although the way the hippocampus encodes memory is not precisely known,
it is thought to occur via a Hebbian mechanism. Indeed, computer modeling, which
retains fidelity to hippocampal cytoarchitecture, suggests that the CA3 region acts as
a network, where arbitrary associations between active stimuli are stored as a code of
modified strengths. Crucially, in this model the change in synaptic strength that
encode the associations are generated by Hebb's rule.
In the 1970s, Kandel and his colleagues established that synapses increase or
decrease in efficiency during learning in Aplysia and that these changes may be short
or long-lived. Two initial discoveries suggested an important role for the
hippocampus in memory formation. Firstly, it was found that during recording from
hippocampal pyramidal cells in conscious rats during exploratory navigation, the
hippocampus could encode information about space (O'Keefe & Dostrovsky, 1971).
Secondly, the synapses within the tri-synaptic circuit of the hippocampus undergo
long-term potentiation (Bliss & Lomo, 1973), called LTP for short.
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Bliss and L0mo discovered, by serendipity, that a high frequency train of action
potentials evoked at any of the three major pathways of the hippocampus produced
LTP, i.e. the persistent increase in efficacy of synaptic transmission lasting hours in
vitro and in the anaesthetized animal and days or weeks in the awake, freely moving
animal. In addition, a theta burst stimulation protocol (several bursts of 4 shocks at
100 Hz separated by a 200 ms interburst interval) also reliably induced LTP (Larson
et a!., 1986) mimicking the firing patterns observed in the hippocampus during
learning tasks (Otto etal., 1991). Indeed, LTP has been suggested to be the
molecular model for learning and memory. This is a widely debated topic, which is
further discussed in more detail in paragraph 1.2.6.
In vitro, LTP is typically measured as the sustained rise in the slope and amplitude of
the field excitatory postsynaptic potential (fEPSP) mediated principally by ionotropic
glutamate receptors in the hippocampus. In the Schaffer collateral commissural
pathway, where CA3 cells synapse with CA1 apical and basal dendrites, LTP is
Hebbian in nature. This can be explained by the properties of the NMDA receptor
and the role of synaptic inhibition in the induction ofLTP by tetanic stimulation.
How Receptors mediate coincidence-detection
It is the voltage-dependent block of the integral channel by Mg2+ that allows the
NMDA receptor to act as a coincidence detector, i.e. the postsynaptic membrane
must be depolarised to remove the Mg2+ block, thereby allowing the entry of Ca2+
through the NMDA receptor upon the release ofglutamate into the synaptic cleft
(Mayer et al., 1984). There is little chance of activating the NMDA receptors
sufficiently to lift their voltage dependence due to Mg2+ blockade by low frequency
stimulation (LFS). The frequency dependence ofLTP induction is largely
attributable to the susceptibility ofNMDA receptor-mediated currents to GABAb
receptor mediated autoinhibition i.e. during a train of stimuli delivered to the
afferents, each subsequent stimulus-evoked release of glutamate produces a larger
NMDA receptor-mediated response in the pyramidal cell due to decreased GABA
release from interneurons as GABA from the previous stimulus inhibits its own
release (Collingridge et al., 1988; Davies et al., 1991). That NMDA receptor
activation requires both glutamate and sufficient depolarisation of the postsynaptic
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membrane to induce LTP, is shown by the finding that the latter process is blocked
by properly timed hyperpolarising pulses and facilitated by blockade of postsynaptic
inhibition using GABA antagonists. Several reasons may account for the large
depolarisation generated by tetanic stimulation as it has the following effects:
(a) it produces sustained glutamate release causing summation of AMPA receptor
mediated EPSPs,
(b) high internal CI" and external K+ renders GABAergic inhibition less effective
due to prolonged activation of both GABAa and GABAb receptors respectively,
causing the equilibrium potentials for these ions to shift in depolarising direction
and
(c) GABAb autoreceptors, during HFS, inhibit GABA release when activated by
GABA, thereby compromising inhibition further.
Once induced, LTP does not depend on the activation ofNMDA receptors any more,
as antagonists to the receptor do not affect expression ofLTP. The maintenance and
expression ofLTP may be pre- and/or postsynaptic in origin. Experimental evidence
suggests that modifications in either synaptic locus are in a delicate balance, which
depends on the protocol of induction and the timescale of the experiment assessing
the activity dependent change following induction. For example, protein synthesis
inhibitors have been shown to inhibit LTP after 3 hours in vitro and both
transcription and translation inhibitors in vivo. However, these drugs do not affect
LTP induced by a less robust HFS protocol.
Thus synaptic potentiation can be temporally categorised into:
(1) short-term potentiation (STP), lasting up to 30 minutes
(2) early-phase LTP (E-LTP), lasting up to 3 hours and
(3) late-phase LTP (L-LTP), lasting up to 8 hours, in vitro.
Table 1.2.2. summarises the characteristics of kinases active during STP and E-LTP.
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Kinase LTP Induction Protocol Activation Timecourse
CaMKII Theta-burst Up to 1 hour
PKA Multiple tetanic Up to 10 minutes
PKC Multiple tetanic Up to 45 minutes
PKM Single tetanic Active in 30 minutes
P42 MAPK Multiple tetanic Active from 2 minutes
SRC Multiple tetanic Active from 1 minute
Table 1.2.2. Temporal characteristics of kinase activation during E-LTP
(Soderling & Derkach, 2000).
L-LTP is thought to depend on protein translation and transcription rather than
kinase activation. There is no a priori reason favouring a common synaptic locus for
the latter components. However, a consensus is emerging that NMDA receptor
dependent E-LTP in CA3-CA1 synapses embraces a postsynaptic locus (Diamond et
al., 1998).
Calcium
Upon activation, the NMDA receptor allows intracellular Ca2+ entry (Dani, Jahr &
Stevens 1987). Increases in intracellular Ca2+ concentration were shown to be vital in
LTP induction (Lynch et al., 1983) as induction is occluded by the intracellular
injection ofEGTA. This was supported by Ca2+imaging techniques, which
visualised this calcium elevation in dendritic spines during high frequency
stimulation (Muller & Connor, 1991). The Ca2+increase appeared to last for several
seconds and produced Ca2+ gradients from spines to dendrites lasting for several
minutes. This is unnecessary for LTP induction, which can be induced by Ca2+
transients of 3 seconds (Malenka et al., 1992). There is also evidence to suggest that
the Ca2+ influx is augmented by (IP3)-induced release of Ca2 and ryanodine receptor
sensitive calcium-induced Ca2+ release from intracellular stores (Obenaus et al.,
1989; Harvey & Collingridge, 1992). Inhibitors of these stores also inhibit LTP.
Although, LTP in the CA1 area is associative, LTP induction in the synapses of
mossy fibres with CA3 pyramidal cells does not depend on NMDA receptor
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activation, nor on intracellular calcium elevation in the postsynaptic neuron. LTP
there appears to be dependent on increased neurotransmitter release from the
presynaptic bouton (Bennett, 2000).
Postsynaptic Modifications: Signal transduction by protein phosphorylation
and dephosphorylation
Support for the postsynaptic hypothesis for associative LTP is that synaptic plasticity
is expressed via an augmented sensitivity of the postsynaptic membrane brought
about by:
(a) an increase in number of receptors
(b) a change in the phosphorylation state of existing receptors, so that they become
more sensitive. Experimental evidence suggests that both AMPA and NMDA
receptors have consensus sequences encoding phosphorylation sites, acted upon
by kinases and phosphatases.
(c) a change in the cytoskeletal systems, brought about by intracellular second
messenger systems e.g. of the scaffolding organelle holding the NMDA and
AMPA receptors attached at the postsynaptic membrane, postsynaptic density
(PSD).
The obvious proteins to upregulate or modify would be ion channels involved in low
frequency synaptic transmission. Accordingly, there is evidence for AMPA receptor
phosphorylation by protein kinases, particularly PKA, following LTP induction
(Matthies et al., 1990). Alternatively, the induction ofLTP could alter the ratio of
flip:flop AMPA receptors or change the subunit composition resulting in a change in
whole cell conductance properties (Sommer et al., 1990). There is some evidence
suggesting that NMDA receptor function can also be enhanced by protein kinase
activity, such as PKC providing a means by which synapses increase their plasticity
as well as their efficacy (Kelso et al., 1992).
Several Ca2+-sensitive enzymes have been proposed to play a part in converting the
induction signal into a persistent change in synaptic efficacy although most interest
has focused on protein kinases. The first evidence that implicated protein
phosphorylation following LTP induction in the perforant pathway of hippocampal
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slices came from Bar et ah, in 1980. They observed an enhanced incorporation of
[32P] into a protein band with a molecular weight of 50 KDa. IfLTP was not
induced, then no enhanced incorporation of [32P] was observed. However, it was not
until 1981, that it was shown conclusively that E-LTP could be blocked by kinase
inhibitors (Lovinger et al., 1981; Reymann etal., 1988a-b; Malinow et ah, 1988). In
1989, it was shown that intracellular injection of the non-selective kinase protein
inhibitor H-7 into CA1 pyramidal neurons blocks LTP induction (Malinow et al.,
1989). Although intracellular injection of H-7 does not block LTP expression
following its induction, it does so when applied extracellularly (Malenka et ah,
1989), which suggests a presynaptic locus for expression while a postsynaptic locus
for LTP induction.
Calcium-dependent Kinases
As mentioned above, LTP induction may be blocked by intracellular calcium
chelators and ser/thr protein kinase inhibitors. Therefore, a role in LTP expression of
CaMKII and/or PKC becomes plausible.
The first kinase to be implicated in LTP was the Ca2+/phospholipid-dependent
protein kinase (PKC) (Bar et ah, 1980). It is generally thought that PKC activation is
not a necessary factor for LTP induction but may be involved in the conversion of
short- to long-term potentiation. Phorbol esters, which are known PKC activators,
were found to enhance synaptic transmission in hippocampal slices, in a manner
similar to LTP (Routtenberg et ah, 1986; Malenka et ah, 1986). Furthermore, it was
shown that PKC activity was elevated twofold in membranes from hippocampal
regions subjected to LTP induction paradigms (Akers et ah, 1986). PKC specific
inhibitors, e.g. PKC-(19-31), block LTP induction (Malinow et ah, 1989). Similarly,
antibodies raised against specific PKC isoforms prevent long-term synaptic plasticity
(Lopez-Molina et ah, 1993; Angestein & Staak, 1997). Active PKC injection to the
postsynaptic site potentiates synaptic plasticity (Hu et ah, 1987). Though the method
of activation during LTP is still under investigation, recent evidence points to the
involvement of G-protein coupled receptors to PLC activation e.g. group I
metabotropic glutamate (mGluRs)(Otani et ah, 1993). Consistent with the above
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observation it has been shown recently that mGluRs constitute a requirement for LTP
induction (Bortolotto etal., 1994, 1995).
Enhanced activity ofPKC in the CA1 area of the hippocampus in transgenic mice
has been reported to aid in their performance in spatial learning behavioural tasks
(Fordyce etal., 1994).
The Ca2+/calmodulin-dependent protein kinase CaMKII has also been implicated in
LTP (Malenka et al., 1989; Malinow et al., 1989; Lledo et al., 1995; Bortolotto &
Collingridge, 1998; Fukunaga & Miyamoto, 1999; Malenka & Nicoll, 1999).
CaMKII is an oligomeric protein (10-12 subunits) and is contained at high levels in
PSD. Its unusual biochemical properties render it capable of sustaining prolonged
kinase activity in response to a transient elevation of calcium in the dendritic spine,
which persists even after the calcium transient is gone. CaMKII targets the native
AMPA receptor following its activation during LTP (Baria et al., 1997a), as shown
in isolated PSD studies (Brown & Schulman, 1995) and cultured hippocampal
neurons (Tan et al., 1994) and the GluRl subunit of the AMPA receptor in HEK293
cells (Baria et al., 1997a). All the above observations are corroborated with the use
of GluR2 subunit knockout transgenic mice, where LTP is slightly enhanced (Jia et
al., 1996). In contrast, in adult GluRl null transgenic mice, LTP is absent in the CA1
area (Zamanillo etal., 1999). The physiological significance of GluRl subunit
phosphorylation by CamKII in all of the above preparations result in potentiation of
AMPA receptor mediated whole-cell current, which could contribute to synaptic
potentiation during LTP. Transgenic mice lacking CaMKII show impaired synaptic
plasticity, inability to form stable place cells and cognitive performance in learning
and memory tasks (Bach et al., 1995; Mayford et al., 1996; Routtenberg et al., 1996).
Recent evidence also points out a role for CaMKII in carbachol-induced, theta-like
rhythmic activity in the CA1 area of the hippocampus in rats; a process thought to
modulate synaptic plasticity during exploratory behaviour in vivo (Alberi et al.,
2000). Finally, other kinases believed to influence LTP expression are cAMP- and
cGMP-dependent protein kinases (PKA and PKG respectively) (Chetkovich et al.,
1991) and the SRC family of tyrosine kinases (O'Dell et al., 1991b).
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SRC Tyrosine Kinases
NMDA receptors form heteromeric channels, which consist mainly ofNR1 and
NR2A-D subunits and they form complexes in the PSD with, amongst other proteins,
PSD-95, Ca2+-Calmodulin and the tyrosine kinase family members (Kennedy, 1998).
Although FYN tyrosine kinases have been shown to be important for LTP expression
in the hippocampus (O'Dell et al., 1991b; Grant et al., 1992; Grant & O'Dell, 1994),
emphasis has been recently put on SRC family of tyrosine kinases.
Phosphorylation of the NR2A and NR2B subunits of the NMDA receptor result in
the alleviation of zinc inhibition and the potentiation of current through the receptor
(Zheng et al., 1998). SRC-specific inhibitors prevent LTP induction (Lu et al., 1999).
SRC or FYN infusion culminates in the potentiation of AMPA receptor mediated
current, which probably results from the enhancement ofNMDA receptor function
(Yu et al., 1997). The aforementioned findings led to the development of the
hypothesis that LTP induction results in the rapid activation of the SRC family of
tyrosine kinases, which enhance calcium influx through the NMDA receptor by
altering its channel properties, via phosphorylation. This, in turn, results in the
activation of calcium-dependent kinases e.g. CaMKII, leading to potentiation of
AMPA-receptor-mediated current (Soderling & Derkach, 2000). The action of
different kinases reflects the temporal segregation of synaptic potentiation phases
(Table 1.2.2.).
The activation of kinases, e.g. CaMKII, is shut down or reversed by protein
dephosphorylation due to the action of phosphatases, such as PP1, PP2A and 2B
(calcineurin)(Soderling & Derbach, 2000). Stable synaptic potentiation requires the
prolonged activation of CaMKII, as mentioned above, which can be maintained by
inhibition of such phosphatases (Makhinson et al., 1999).
Further Postsynaptic Modifications
Other mechanisms contributing to E-LTP induction and expression include the
'silent synapse' hypothesis, which states that prior to LTP induction some synapses
do not have operative AMPA receptor channels, while following LTP induction they
exhibit AMPA receptor mediated currents (Isaac, Nicoll & Malenka, 1995; Liao et
al., 1995; Isaac et al., 1998). This might result from the rapid insertion of AMPA
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receptors into the postsynaptic membrane from an intracellular pool, which is
thought to be protein a phosphorylation-dependent process. Consistent with this
hypothesis, postsynaptic infusion of the membrane fusion pathway, such as N-
ethylmaleimide-sensitive factor (NSF) and soluble NSF attachment protein (SNAP),
depress LTP (Lledo et al., 1998). Infusion of SNAP enhances LTP and this
enhancement is occluded by prior induction ofLTP. NSF and SNAP both bind to the
GluR2 subunit and disruption of the formation of this complex results in the rundown
of AMPA receptor mediated whole cell current (Noel et al., 1999). Finally, calcium
seems to promote exocytocis of dendritic organelles, which is thought to be a
CaMKII dependent process (Maletic-Savatic et al., 1998). Hence, there seems to be
AMPA receptor translocation to the postsynaptic membrane going on following LTP
induction. However, the functionality and precise location of these receptors have yet
to be shown. The use of protein synthesis inhibitors has demonstrated that protein
synthesis from existing mina is required for the maintenance ofL-LTP during the
first few hours (Krug et al., 1984; Obtain et al., 1989; Frey et al., 1989). However,
there is also evidence for gene transcription and increased mina production after
tantalization (Hackler et al., 1992; Dragoon et al., 1989; Nicole et al., 1991). Of
particular interest is the involvement of camp-response-element-binding-protein
(CREB)-mediated transcription in LTP, as indicated by genetic studies in
Drosophilae and Alyssa. However, it is not clear which kinases are responsible for
CREB phosphorylation during LTP (Frank & Greenberg, 1994).
Presynaptic Modifications
As well as postsynaptic modifications, presynaptic modifications have also been
considered as a locus of LTP expression. However, a presynaptic hypothesis for LTP
expression has to explain how an initial postsynaptic triggering event may cause a
sustained increase in glutamate release. This concept originally maintained by Bliss
& Collingridge and independently by Kandel, challenges the original concept voiced
by Sherrington that synapses are polar and that electrical communication between
neighboring neurones is synapse-specific.
One such idea is that this process may involve diffusable retrograde messengers.
Two such candidates are arachidonic acid and nitric oxide (NO) (McNaughton, 1982;
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Schuman & Madison, 1991; O'Dell et al., 1991b), which could act to increase
glutamate release or decrease glutamate uptake into surrounding glia. The functional
significance of the retrograde messengers is currently an issue of debate, due to the
fact that their effect may not be synapse specific and to the lack of incontrovertible
evidence supporting their existence. Another idea implicates presynaptic protein
kinase activity in LTP expression in CA3 synapses between pairs of hippocampal
neurons. Direct injection of the non-selective kinase blocker H-7 into the presynaptic
neurone, inhibits LTP expression probably by restricting glutamate release (Pavlidis
et al., 2000).
Long-term Depression
Long-term depression (LTD) is a long-lasting, activity-dependent reduction in
glutamatergic synaptic strength most prominent in the hippocampus and cerebellar
cortex (Christie et al., 1994, 1996; Goda & Stevens, 1996). In the CA1 area
repetitive, low frequency stimulation (1-5 Hz) of a synapse causes a gradual
reduction in the slope and amplitude of the fEPSP, which is stable for more than an
hour. Such homosynaptic LTD is input-specific and depending on the area of the
brain can be induced by a variety of stimulation protocols. For example, in the
striatum LTD induction requires tetanic stimulation. Like LTP, LTD has cooperative
and associative properties.
LTP and LTD interact (Abbot & Nelson, 2000) and in the CA1 area their induction
depends on the activation ofNMDA receptors (Dudek & Bear, 1992; Mulkey and
Malenka, 1992). There is a wealth of evidence suggesting that both LTP and LTD
are mechanistically similar, for example induction of both depends on intracellular
calcium levels and blocked by inhibitors of intracellular calcium stores. Hippocampal
LTD depends on a critical level of depolarisation partly mediated by NMDA
receptors, but is not always inhibited by NMDA receptor inhibitors.
Finally, it has been proposed that the phosphorylation state of CaMKII, which
critically depends on intracellular calcium levels, determines synaptic strength
(Lisman, 1985; Lisman & Goldring, 1988; Lisman, 1994). If the phosphorylated
form predominates then the synapse undergoes LTP, while if the concentration of the
dephopshorylated form is higher, LTD is favoured. The phosphorylation state of
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CaMKII is determined by calcium dependent phosphatase enzymes e.g. PP1 (Dudek
and Bear, 1992; Mulkey and Malenka, 1992).
1.2.6. Role of LTP in Learning and Memory
One of the reasons why hippocampal synaptic plasticity is one of the major research
interests of neuroscience is the generally shared belief that the mechanisms
underlying plasticity are common to those facilitating learning and memory.
Evidence in support of this concept has recently been reviewed by Martin et al.
(2000).
Although, the fact LTP induction subsides as the animal gets older was already
known, no causal relationship was established between them (Barnes, 1979). This
came with the discovery that in behavioural tasks assessing memory and learning in
rats, e.g. the Morris water maze task, their performance is disrupted by NMDA
receptor antagonists, such as D,L-AP5. This observation points to LTP as the
underlying mechanism for hippocampus-dependent spatial navigation and learning
(Morris et al., 1986). Place learning is a hippocampus dependent process (O'Keefe,
1999). The inactive L-isomer of AP5 did not have any effect on spatial learning in
rats tested. As there was no impairment in LTP-independent visual discrimination
tasks, the findings established a correlation between LTP and hippocampus-
dependent spatial learning. Furthermore, it was found that saturation ofLTP in the
pyriform pathway to the dentate gyrus in vivo impaired spatial learning
(McNaughton et al., 1986; Castro et al., 1989).
Targeted knockout mutations are being increasingly used to allow the relationships
between learning and cellular processes to be identified. In most, but not all studies,
impairment in hippocampal synaptic plasticity is accompanied with cognitive deficits
and with a parallel distortion of place cell properties (Tsien, 1996; Rampon et al.,
2000). Nevertheless, this experimental approach has been heavily critisiced on the
grounds that during the development of transgenic animals any number of secondary
alterations may occur as a result of the primary mutation and that these may be
responsible for the altered phenotype (Gerlai et al., 1998). Tsien et al. surpassed this
problem by pioneering a time-dependent targeted mutation occurring in mice after
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hippocampal development is completed only in CA1 hippocampal cells. Floxed
NMDAR1 mice fail to show NMDAR-dependent LTP in the CA1 accompanied by
impaired performance in the watermaze task and coupled with distorted place cell
properties in the CA1 area. Further elucidation of the role of the hippocampus in
learning and memory will follow if similar strategies are used to target precicely
timed gene mutations in other regions, such as the CA3 and entorhinal cortex. The
role of transgenic approaches in the development of mouse models of learning and
memory will be discussed in paragraph 1.4.
It is noteworthy that there is growing experimental evidence to support the role of
LTP-like, plasticity related processes in neuronal growth, development and death in
most parts of the mammalian brain. However, as much as synaptic transmission and
plasticity depend on glutamatergic excitatory neurotransmission, there are other
important neurotransmitter inputs to the hippocampus, which are thought to modulate
learning and memory, like acetylcholine (reviewed in Pepeu, 2001) and galanin
(Ukai et al., 1995; O'Meara el al., 2000). In the next paragraph, a brief review on the
major cholinergic projection, the septohippocampal pathway, to the hippocampus
will be presented.
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1.3. The Septohippocampal Pathway
The septohippocampal pathway is one of the best examples of a central cholinergic
pathway and provides most of the cholinergic innervation of the hippocampal
formation. It also holds a critical role in the generation and maintenance of various
forms of electrical rhythmic activity, e.g. the theta rhythm, implicated in the spatial
memory acquisition of the rat (Winson, 1978). The septohippocampal pathway is
notably susceptible to the ageing process and, furthermore, the target of
neurodegenerative diseases such and Alzheimer's disease where loss of cognitive
function, particularly memory, is a major symptom.
1.3.1. Anatomical Structure
The septohippocampal afferents project from large neurons located in the medial
septal nucleus (MS) and the vertical limb of the diagonal bands ofBroca (vDBB).
These neurons form a continuum of cells that are difficult to subdivide because of the
absence of clear histological boundaries.
It has been demonstrated that choline acetyltransferase (ChAT)-positive axons
infiltrate the hippocampus at postnatal day 2 in the rat (Hofmann & Ebner, 1985) and
the intensity of ChAT staining increases until the third to fifth week (Gould et al.,
1991).
The majority of septal neurons innervate the ipsilateral hippocampus via three main
routes: the fimbria, the dorsal fornix, and the supracallosal striae (Gage et al., 1984).
A topographical projection of afferents has been shown, the more laterally the septal
neurons are located the more ventrally the axons terminate within the hippocampus
and the more rostral neurons project to the rostral parts of the hippocampus (Amaral
& Kurz, 1985; Gaykema et al., 1990). In addition, it has been demonstrated that the
CA1 pyramidal cells and granule cells of the dentate gyrus receive afferents from
vDBB whereas the cells of the ventral hippocampus receive afferents from both the
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vDBB and the MS (Nyakas et al., 1987). Furthermore, two sets of septohippocampal
fibres that terminate on the dendrites of pyramidal and granule cells have been
described: (1) thick, coarse axons with large terminal boutons present in the strata
oriens, radiatum, moleculare, the dentate gyrus and the infragranular zone of the
dentate gyrus and (2) thin fibres displaying varicosities in the hippocampal pyramidal
cell layer, the dentate granular layer and the middle one-third of the dentate
molecular layer (Nyakas et al., 1987; Gaykema et al., 1991).
1.3.2. Distribution of Neurotransmitters and Neuropeptides
Stimulation and lesion studies as well as histochemical detection of the enzymes
acetylcholinesterase (AChE) and choline acetyltransferase (ChAT) led to the
discovery that a proportion of the septohippocampal pathway was cholinergic.
Lesions of the MS or fimbria/fornix transection resulted in a decrease in ACh,
choline and choline uptake in the rat hippocampus paralleled by a decrease in ChAT
(Sethy et al., 1973). In addition, electrical stimulation of the septum induces an
activation of pyramidal cells in the hippocampus and dentate gyrus (Andersen et al.,
1971), supported by in vivo release ofACh in the hippocampus after medial, but not
lateral, septal stimulation (Dudar, 1975).
AChE and ChAT have been detected in the rat hippocampus (Fonnum, 1970; Shute
& Lewis, 1966) at axon terminals that make synaptic contacts on dendrites of
pyramidal and granule cells, mainly on dendritic spines. Immunohistochemical
studies have confirmed the presence of ChAT-positive cell bodies of two types: (1)
small, round neurons of the medial septal nucleus and (2) larger, fusiform neurons of
the vDBB (Amaral & Kurz, 1985). Staining for ChAT revealed preferential
distribution of cholinergic terminals in the hippocampal pyramidal and dentate
granular layers as well as at layers adjacent to them, with the highest density in the
stratum oriens (Houser et al., 1983). As well as synapsing with the dendritic spines
of pyramidal cells, cholinergic fibres synapse with GABAergic and somatostatin-
containing neurons in the stratum oriens of CA1 and CA3 subfields.
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Histochemical studies have also demonstrated a GABAergic subpopulation of
septohippocampal neurons making up 10-30% of the afferents (Kohler et al., 1984).
In contrast to the cholinergic afferents, the GABAergic septal neurons terminate
mainly on GABAergic interneurons (Freund & Antal, 1988).
However, not all of the neurons of the septohippocampal pathway are cholinergic or
GABAergic. As such, it has been demonstrated that medial septal cells contain
neuropeptides such as galanin and A-acetyl-aspartyl-glutamate (NAAG), which in
some afferents are co-released with ACh (Forloni et al., 1987; Melander et al.,
1986a-b).
1.3.3. Role of Septohippocampal System in Learning and Memory
The involvement of the septohippocampal system in the processes of learning
memory has been ascertained from several lines of investigation including lesion and
pharmacological studies, behavioural performance and behavioural recovery after
lesion.
Lesions of the MS or fimbria-fornix lead to a deficit in working memory, especially
in spatial tasks (Olton et al., 1978a-b; Poucet & Herrmann, 1990). However, the
exact way in which the septohippocampal pathway contributes to memory related
tasks is complicated by the fact that the lesions also destroy other pathways en route
to the hippocampus such as the noradrenergic and serotonergic pathways, as well as
local neurons in the case of the MS lesion. However, immunotoxic lesioning of rats
using the specific cholinergic immunotoxin, 192-IgG saporin, produces long lasting
spatial learning impairments after cholinergic denervation.
Microinjection of phenoxybenzamine, an a-noradrenergic receptor antagonist, or
bicuculine, a GABAa receptor antagonist, caused an impairment of working memory
(Chrobak et al., 1992; Marighetto et al., 1989) suggesting an involvement of
noradrenergic and GABAergic neurotransmission in the functioning of the
septohippocampal system. Cholinergic antagonists, such as scopolamine, have long
been known to impair many types of memory tasks.
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Following learning tasks, increased ChAT and ACh levels have been observed
(Jaffard et al., 1980) as well as increases in sodium-dependent high affinity choline
uptake (HACU) in the rat hippocampus and frontal cortex (Kuhar et al., 1978; Rauca
et al., 1980). It has been demonstrated that biochemical markers of
septohippocampal cholinergic activity recover back to control levels within 6 weeks
after lesions limited to the supracollosal pathway (Gage et al., 1983). One study
shows an upregulation of ACh synthesis and storage in the hippocampus after partial
fimbria-fornix lesion (Lapchak et al., 1991) and this recovery is potentiated by
various neurotrophic factors, especially NGF. This evidence demonstrates a capacity
of the septohippocampal system to compensate for loss of function.
1.3.4. Involvement in Aging and Disease
The septohippocampal pathway is vulnerable to aging. In the rat, a decrease in the
number and size of AChE-positive MS-DBB neurons has been observed with age
(Biegon et al., 1986; Fischer et al., 1989) whereas only a decrease in the size of
AChE-positive cells is seen in the mouse (Hornberger et al., 1985). This appears to
correlate with a behavioural deficit (especially in learning and memory tasks)
(Fischer et al., 1989). Similar age-related changes seem to occur to the human
nucleus basalis ofMeynert (De Lacaille et al., 1991). In addition to neuronal loss, the
sensitivity of hippocampal neurons to cholinergic agonists is decreased both in vivo
and in vitro (Lippa et al., 1981; Segal, 1982a; Potier et al., 1992). Additionally, it has
been shown that the slow EPSP, due to the evoked release ofACh from
septohippocampal neurons, is dramatically depressed in the aged rat (Potier et al.,
1992).
Presenile dementia, such as that found in Alzheimer's disease (AD), incorporates
many cognitive impairments including memory loss. Since the 1970's, ACh deficits
have been implicated in the pathophysiology of AD, e.g. a significant and selective
loss of ChAT activity in different parts of AD brain samples (cortex, hippocampus
and amygdala) was demonstrated (Bowen et al., 1976, 1979). This was supported by
the observation that neurons in the basal forebrain were degenerated in AD
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(Whitehouse et al., 1981), explaining the reduced ChAT activity in the cortex and
hippocampus. Other studies have demonstrated reductions in ACh levels (Richter et
al., 1980), ACh synthesis (Sims et al., 1980) and high affinity choline uptake. In
addition, an inverse relationship was found to exist between ChAT and AChE
activities in the cortex and the number of senile plaques, a pathological marker that is
argued to correlate with AD progression (Perry et al., 1978).
The development of mouse transgenic models for neurodegenerative diseases has
shed some light on the mechanisms underlying the pathology of several diseases
especially senile dementia and dementia of the Alzheimer's type. As this thesis will
be dealing with the synaptic processes underlying learning and memory in rodents in
health and disease and particularly focusing on mouse models of the ageing brain, a
brief account is laid out here of research performed on existing mouse models of
dementia.
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1.4. Transgenic Models ofLearning and Memory
In an attempt to link Hebbian LTP to memory formation several approaches have
been used in neuroscience research. In section 1.2.6., some of them were described,
namely the use of behavioural tasks assessing learning and memory in combination
with pharmacological manipulations thought to disrupt synaptic plasticity in the
hippocampus in vitro (Collingridge el al., 1988; Morris el al., 1986; McNaughton el
al, 1984). These methods, although innovative at the time, did not account for the
effects of non-region specific drug diffusion and drug toxicity, factors which may
interfere with learning behaviour. An alternative method is to use genetic models to
examine the correlation between LTP and memory. Such models rely on the design
and production of mutant animals and the analysis of the impact of the manipulated
gene on synaptic plasticity in vitro and on the performance of animals in learning and
memory paradigms. When genes resulting in proteins that regulate LTP are aberrant,
synaptic plasticity is usually disrupted and this may be accompanied by a
concomitant impairment in spatial learning.
How reliable is the correlation between LTP and learning then?
Although this is usually the expected outcome, there are exceptions to the rule e.g. in
mice lacking GluRl subunit of the AMPA receptor complex basal transmission is not
affected, but LTP is impaired. Interestingly, these mice do not show any cognitive
deficits in spatial learning acquisition (Zamanillo el al., 1999). Another example
comes from mutant mice lacking the gene for PSD95 protein, which show enhanced
LTP in vitro, but impaired performance in the Morris watermaze task (Migaud et al.,
1998).
Disadvantages of the genetic approach
The genetic approach may result in the 'gain-of-function' phenotypes in transgenic
mice, as many recent reports claim. For example, in GluR2-null mice an enhanced
NMDA receptor - independent LTP was observed, coupled with a ninefold increase
in kainate induced calcium permeability. These mice showed several behavioural
anomalies, probably due to the lack of GluR2 during development (Jia el al., 1996;
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Gerlai et al., 1998). In transgenic mice overexpressing the constitutively active form
ofFYN in the forebrain, LTP was reported to be enhanced and was induced by low
threshold theta stimulation (Lu et al., 1999). In addition, GABAergic inhibition was
compromised.
Furthermore, the behavioural phenotyping of the cognitive performance of mutant
mice mostly consists of the Morris watermaze task, when other tests should be used
as well, such as hippocampus-dependent non-spatial tasks e.g. novel object
recognition task, contextual fear conditioning and social transfer of food preference.
Differences in the genetic background of mutant mice are not the only reason to
account for differences in the behavioural tasks. Other factors include differences in
the experimental execution, handling of the animals and the lack of standardized
behavioural testing conditions. Moreover, as not every genetic method guarantees
molecular specificity, failure to detect a behavioural phenotype may arise from
genetic compensation or inherent insensitivity of the behavioural test. Finally, as the
traditional knockout approach introduces a null mutation in every tissue throughout
development, interpretations of these transgene animals should be done to account
for any possible developmental change and genetic compensation at both the
synaptic and behavioural level.
Interpreting the Phenotype of Knockout Mice
The genetic approach has proven more specific than the pharmacological approach,
especially in cases where the antagonists are not specific to the different receptor
subtypes e.g. 5-HT1B knockout mice have revealed a role in the anti inflammatory
effects of sumatriptan and the anorectic effects of fenfluramine (Yu et al., 1996;
Lucas et al., 1998). However, if the mutated gene is not present throughout
development may yield no or unexpected phenotypic changes in the adult animal.
The absence of the gene may cause developmental compensation from other genes to
make up for the loss and render a viable adult organism. For example, mice bearing
null mutation for either eNOS or nNOS do not show impaired LTP. However, double
knockouts for both genes show a clear deficit in LTP (Son et al., 1996). Null
mutations may affect the expression of neighbouring genes e.g. in the case of pGK
NEO promoter, which reduces expression of downstream Hox genes. The genetic
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background strain is very important when trying to determine phenotypic
characteristics of a knockout mouse strain e.g. 5-HT1B mice have been shown to
display differences to alcohol preference as a result of a drift in their genetic
background (Phillips et al., 1999). Other factors confounding the interpretation of a
knockout phenotype include maternal behaviour (Liu et al., 1997) and pleiotropy e.g.
in 5-HT1A receptor knockout mice, it is unclear whether the phenotype of increased
anxiety is due to presynaptic, postsynaptic receptors or both.
The conditional knockout
The first region- and cell type-specific knockout was produced by Tsien et al., in
1996. The adult mice did not express the NR1 subunit of the NMDA receptor in CA1
pyramidal neurons and this modification resulted in the complete loss ofNMDA
currents, STP, LTP and LTD in the CA1 area, while the gross anatomy of the area
remained intact. These mice were cognitively impaired in hippocampus dependent
tasks assessing both spatial and non-spatial learning (Rampon et al., 2000), but were
normal in hippocampus independent tasks, such as cued fear conditioning. Analysis
of the conditional knockout showed that the NMDA receptor is crucial for plasticity
induction in the CA1 area and for spatial learning and memory. Interestingly,
overexpression ofNR2B subunit of the NMDA receptor channel in the forebrains of
transgenic mice led to an enhancement of LTP and an enhanced performance in six
different behavioural tasks, but had no effect on LTD in the CA1 area (Tang et al.,
1999). These experiments further strengthen the role of the NMDA receptor as a
coincidence detection switch for linking Hebbian LTP and learning and memory in
rodents.
The first successful transgenic model of disease
The first successful transgenic mouse model of Alzheimer's disease was developed
in 1995 by Dora Games et al. (1995). It involved the overexpression of V717F
human (3-amyloid precursor protein, which rendered a mouse strain with aspects of
Alzheimer-type neuropathology. More specifically the mutant mice show an age-
dependent development of neuritic plaques, synaptic loss and gliosis. This discovery
confirmed the role of V717F P-amyloid precursor protein (PDAPP mice) in the
development of hallmark anatomical features of dementia. These mice develop many
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hallmark AD neuropathologies including AP deposition into senile plaques in the
hippocampus and cortex, neurodegerative changes and astrocytosis, microgliosis and
the deposition of acute phase proteins. The brain regions most affected are those
areas associated with early and extensive damage in AD. These neuropathological
changes in the transgenic mice have been confirmed in at least five generations of
animals. The AD symptoms investigated are displayed in a robust manner that
increases with age and gene dosage. The model provides evidence that abnormal
APP processing and AP deposition can result partly in AD like neuropathology and
can contribute to a mechanistic understanding of AD as well as providing a useful
model for the testing of various therapeutic interventions directed towards specific
aspects of the neurodegenerative process (Chen et al. 1998). In agreement with the
above findings, impaired synaptic plasticity and learning, and impaired histology
were observed in hAPP695SWE mice (Chapman et al., 1999).
Finally, Lewis et al., (2001), managed to generate a transgenic mouse model bearing
both major hallmarks of AD, i.e. amyloid plaques and neurofibrillary tangles and
neurofibrillary tangles celebrating the possibility that genetic manipulation of mice
may result in experimentally useful models of neurodegerative disease.
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FynKo NA NA >wt NA <Wt NA Lu et al., 1999
GAP-43
Tg
NA NA ND ND >wt >Wt Routtenberg et
al., 2000
Table 1.4.1. Some Trangenic models developed, where gross anatomy of the hippocampus,
synaptic transmission and plasticity in the CA1 area have been characterized (ND = no
defference, NA = not analysed).
7.5. Aims
This thesis investigates neuronal mechanisms that may play a critical role in learning
and memory. Specifically, the aims are to investigate further the mechanisms
underlying LTP induction and maintenance in vitro, in the galanin deficient mouse
strain with a view to defining the role ofgalanin (Chapter 4) in synaptic transmission
and plasticity in the CA1 area of the hippocampus. Physiological experiments will be
reported in the context of anatomical and behavioural studies. Further aims include
the investigation of the role of galanin in synaptic transmission and plasticity in the
CA1 Schaffer collateral commissural pathway in the rat by way of exogenously
applied galanin, the assessment of the effect of the known galanin antagonist, Ml 5,
by administering it alone or co-applied with galanin and the comparison of synaptic
transmission and plasticity processes in the rat with mutant and wild-type transgenic
mice lacking galanin (Chapter 5). This research is considered important for the






All experiments were performed using standard intra- (Morton & Davies, 1997) and
extracellular electrophysiological recording techniques (Coumis & Davies, 1998).
Synaptic recordings were made from the CA1 region of transverse parasaggital rat
hippocampal slices obtained from 3-week old female Cobb-Wistar rats. All
recordings from transgenic mice were also made from the CA1 region of transverse
parasaggital mouse hippocampal slices obtained from male/female 129sv mice
(Wynick etal., 1998; O'Meara et al., 2000).
2.1.2. Preparation of rat hippocampal slices
The rats were killed by cervical dislocation and were subsequently decapitated in
accordance with U.K. Home Office guidelines (Schedule 1). The brain was rapidly
removed and placed immediately in ice-cold (0-4°C) artificial cerebrospinal fluid
(ACSF). The brain, minus the cerebellum, was hemisected and an agar block fixed to
the base of each hemisphere using superglue. The hemisphere was then fixed to a
polypropylene block for the subsequent cutting of 400 pm thick transverse slices
using a vibroslicer (Campden Instruments, Loughborough, UK). Throughout the
slicing procedure the brain and slices were held in a chamber containing ice-cold,
oxygenated ACSF. The slices were then transferred to a glass petri dish containing
ACSF at room temperature (18-24 °C). A shallow petri dish was preferred than a
200ml beaker/tea strainer design, because the former allows for better oxygenation of
the slices without damaging them.
The hippocampus was cut away from the rest of the brain slice and the CA3 region
cut away mainly to eliminate changes in network function that can occur due to
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epileptiform bursting in that area only when picrotoxin is applied to the slice or
otherwise stated.
Following an incubation period of at least an hour, the resultant slices were placed in
the recording chamber upon a nylon mesh at the interface of warmed (32 ± 2 °C),
perfusing (1-3 ml min'l) ACSF and an oxygen-enriched (95% O2, 5% CO2; BOC
Medical Gasses, UK), humidified atmosphere (Fig. 2.1). Slices were transferred
using either a wide-bored Pasteur pipette or a wet painter's brush (No3). The slices
were then allowed to equilibrate in this environment for approximately one hour
before any electrophysiological recording was attempted. For some experiments, a
submerged chamber was used allowing the flow of ACSF at approximately
2.5ml/min to allow better optics of the slices. This was achieved by an Olympus
microscope and using both XI0 and X40 magnifying lenses. Surplus slices contained
in the petri dishes remained viable for several hours. If required, these slices could be
transferred to the recording chamber at a later time. Equilibration period before
recordings was essential to allow for recovery from excitotoxic amino acids,
proteases and potassium ions, which are released because of cell damage during
dissection. Slices were viable for up to 18 hours following dissection, as they were
prepared from adult rodents.
The standard perfusion medium comprised (in mM): NaCl, 124; KC1, 3; NaHCCL,
26; NaH2P04, 1.25; CaCI2, 2; MgSCL, 1; D-glucose, 10; and was bubbled with 95%
02, 5% CO2 to maintain a pH of 7.4-7.5. ACSF was made up from solid salts using
distilled water filtered (10-18 MD Cm"1) using the Millipore Milli-Q filter system
(Millipore; Molsheim, France) and all chemicals were ANALAR grade (BDH
Chemicals Ltd., Poole, UK).
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2.1.3. Preparation of transgenic mouse hippocampal slices
Galanin transgenic mice were obtained by the Wynick group in Bristol and not by
myself, as follows:
A mouse 129sv cosmic genomic library was screened using a full-length rat galanin
cDNA as a probe under high stringency. A positive/negative selection-targeting
vector was constructed with the signal peptide for the coding region for galanin and
most of the galanin associated peptide removed. The vector was linearised and
electroporated in an E14-embryonic stem cell line. In total, nine clones were
identified. The galanin loss of function mutation has been bred to homozygosity in
the 129/OlaHsd mouse strain. Galanin levels were measured using
radioimmunoassay in several brain regions, stomach and small intestine. Levels in
heterozygotes were 50% ofwild-type controls while levels in homozygotes were
below the limit of detectability in all cases. Results of genotype analysis of live births
were in the expected ratio predicted by Mendelian genetics and the sex ratio of
homozygote offspring was 1:1 (Wynick et al., 1998; O'Meara et al., 2000).
The mouse brains were extracted and maintained as above with the exception that the
CA3 region was not removed. Slices were placed in a submerged recording chamber
perfused (1-3 ml min"l) with warm (30-32°C) ACSF and held in place by short
pieces of interwined silver wire.
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2.2. Recording Set-Up
2.2.1. Intracellular recording from rat brain slices
The recording chamber and the micromanipulators were mounted on magnetic stands
(Narishige, Japan) supported on a steel plate on an anti-vibration table (Ealing, MA,
USA). A steel Faraday cage, grounded through the amplifier (Axoclamp-2B, Axon
Instruments, CA, USA), was placed around the recording system in order to isolate it
from extraneous electrical noise. All electrical equipment that was fitted with earth
leads was secured in a rack and earthed through the mains.
The recording chamber was a modified version of an interface electrophysiological
recording chamber designed by Spencer etal. (1976) (Fig. 2.1). It consisted of an
outer water bath with a centrally mounted platform on which the tri-compartmental
recording chamber was secured. The outer water bath was partially filled with
distilled water and was bubbled with a 95% O2, 5% CO2 mixture. The height of the
covering lid was adjusted to allow the oxygen-enriched humidified atmosphere to
flow over the slices.
ACSF was pumped, by means of a peristaltic pump (Watson-Marlow, England), to a
gravity-feed syringe. This fed a constant flow (1-3 ml min"1) of ACSF into the first
well of the recording chamber. The ACSF then flowed around the circumference of
this well and through a small inlet into the recording chamber proper. Here, it flowed
underneath the nylon mesh and was removed through a separate outlet by suction
through a syringe needle connected to a water-powered suction pump (Brownall,
England). By adjusting the height of the gravity feed and the magnitude of the outlet
suction, the level of ACSF in the recording chamber was maintained so that it was in
contact with the mesh but did not cover the slices. A heated patch connected to a
constant current source (Maplin XG89, Taiwan) was attached to a metal plate in the
base of the water bath (Fig 2.1) to maintain the temperature at 32 ± 2 °C.
The slices in the recording chamber were epi-illuminated with a fiber optics system
(Nachet, France). All stimulating and recording electrodes were mounted on
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micromanipulators (Narishige, Japan) which allowed movement in the x, y and z
axes. An additional single axis fine movement hydraulic manipulator (Narishige,
Japan) was used for the recording electrode to allow increased sensitivity when
advancing the electrode for the impalement of neurones. To enable the positioning of
electrodes in the slice, the slice was viewed using an overhead dissecting angle
microscope (M3C, Leica, England). Recording microelectrodes were placed, at an
approximately 45° to the vertical, in either stratum oriens (CA1 pyramidal basal-
dendritic layer) or stratum radiatum (CA1 pyramidal cell apical dendritic layer).
During the acquisition of the experiments contained in this thesis ACSF was not
recycled.
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Figure 2.1. The interface recording chamber. This figure shows a schematic representation of
the recording chamber as viewed from above (A) and from the side (fl). ACSF, perfused with
95% 02/5% C02 and maintained at 32°C, was passed through tubing immersed in the
temperature controlled external water bath and into the interface chamber. The level of ACSF
in the interface chamber was maintained just above the level of the nylon mesh which supported
the slice. Waste ACSF was drawn off by suction through a hypodermic needle. The humidified
atmosphere was maintained by passing 95% 02/5% C02 through distilled water maintained at




Extracellular recordings were done as described above except for that experiments on
transgenic mice were performed using a slightly different set-up as regards the
recording chamber itself. This comprised a recording bath mounted on a fixed stage
upright microscope (Olympus). ACSF flowed into the slice holding chamber by
gravity feed and was removed by a suction needle placed in an adjoining chamber
connected to a peristaltic pump (Watson Marlow, UK). ACSF was not recycled.
2.3. Recording Techniques
2.3.1. Recording electrodes
Microelectrodes were pulled from thick walled (internal diameter: 0.69 mm; external
diameter: 1.2 mm) borosillicate glass capillaries with an inner filament (120F-10,
Harvard Apparatus, England), on a horizontal Flaming-Brown P-97 micropipette
puller (Sutter Instruments Co., USA). Intracellular microelectrodes were back-filled
with 2 M potassium methylsulphate (ICN Biomedicals Inc., USA) and had
resistances ranging 60-120 MO. Thin walled extracellular microelectrodes (internal
diameter 0.86mm, external diameter 1.5mm) resistances ranging 1-5 MO were back¬
filled with 2 M sodium chloride (150F-10, Harvard Apparatus, England).
Recording microelectrodes were then mounted in electrode holders (Harvard
Apparatus, England) allowing the electrolyte solution within the microelctrode to
make contact with a silver chloride coated silver wire. The holders were inserted into
unity gain head stages (current gain x 0.1 or x 1.0: Axon Instruments, CA, USA) and
connected to an Axoclamp-2B amplifier through the microelectrode 1 (ME1) port for
use in "bridge balance" or "discontinuous current clamp" (DCC) modes. A silver-
silver chloride bath reference electrode, submerged in the recording chamber, was
also connected to the head stage and grounded through the Axoclamp amplifier.
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2.3.2. Intracellular recording
Impalement of CA1 pyramidal neurones was achieved by manually advancing the
recording microelectrode through the slice using the hydraulic vertical axis
manipulator, and intermittently applying a 1-2 ms "buzz" from the Axoclamp-2B.
"Buzzing" momentarily increases the capacitance neutralization of the electrode and
causes the headstage to oscillate at high frequency. This procedure aids penetration
of cells when the electrode is opposed to the cell membrane although the mechanism
by which this occurs is unclear. Cell impalements/recordings was routinely
performed in normal ACSF and only after a stable recording was obtained for at least
10 min were drugs administered. The membrane potential (Vm) of the neurone (as
measured by the Axoclamp 2B amplifier) was measured as the potential difference
between the microelectrode and the bath reference electrode. Prior to searching for
cells, when the microelectrode had been positioned extracellularly in the slice, Vm
was set to zero. Immediately following the end of each experiment this reading was
checked again and any correction in the recorded membrane potential made.
2.3.3. Current injection
Before searching for cells the resistance of the microelectrode was measured in
bridge balance mode. This was done by balancing out the unwanted potential drop
across the microelectrode resistance through a differential amplifier incorporated in
the Axoclamp 2B amplifier. The mode of recording was then switched to
discontinuous current clamp mode which allowed rapid switching (frequency 3-5
kHz) between current injection and voltage recording. Thus, current was injected
during the first 30 % of the cycle and the resulting potential across the
microelectrode resistance due to charging continually monitored on an oscilloscope.
The capacitance neutralization was increased so that when the cell Vm was sampled,
just prior to the next current injection, the potential across the microelectrode tip had
fully decayed. Low resistance microelectrodes (60-90 MD) allowed the most
accurate recording of membrane potential during current injection.
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2.3.4. Amplification and Filtering
Synaptic potentials recorded through the ME1 port on the Axoclamp-2B amplifier
were amplified 10 fold by an in-built gain. In DCC mode the amplifier set the sample
rate (3-5 kHz switching frequency). Signals above 1-3 kHz were filtered, using a
low-pass filter, which did not noticeably affect the waveform of the synaptic
potentials. Secondary amplification of synaptic responses was provided by variable
gain DC amplifiers (Neurolog, Digitimer, England). The output signals were then
digitally filtered through a Digidata 1200 interface (Axon Instruments Ltd.)
connected to a Dell Dimension P75t IBM personal computer (PC) (Dell, Texas,
USA). Any further filtering was carried out during off-line analysis with Clampfit
software (Axon Instruments Ltd.).
2.3.5. Data display and storage
Digitized data were captured and simultaneously viewed using pClamp6 software
(Axon Instruments Ltd.) on the PC. Digitized records were stored on the hard disk of
the PC for off-line analysis using Clampfit software (Axon Instruments Ltd). The
potential drop across the microelectrode in discontinuous current clamp mode was
monitored on an analogue oscilloscope (Phillips, Holland). A continuous chart record
or digital tape (DAT) record of the membrane potential of the cell was captured by a
chart recorder (Gould, Ilford, Essex, UK) or DAT recorder (DTR1404, Biologic
Scientific Instruments, Claix, France). This provided a means to assess the passive
stability of the cell throughout each experiment.
2.3.6. Extracellular recording
Extracellular field potential recordings from the apical and basal dendritic layer of
CA1 pyramidal cells were made with respect to the reference electrode and the rising
slope and/or peak amplitude of the fEPSP was measured (Figure 2.2). Data were
displayed (amplification output gain *500 and lowpass Bessel filtering at 5KHz)
and stored in a similar manner to that used for intracellular recording. For the
majority of extracellular LTP experiments, a piece of software called LTP (Version
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1.14J) was employed which allowed the recording, averaging and on-line analysis of
data (written by William Anderson, University ofBristol).
A 0.2
DETECTION, BDO/SO
Baseline: 8 to 2ms before pulse
Peak: li to 10ns after pulse ft/P/N:fl
Slope: 3.5 to 5ns after pulse
Figure 2.2. fEPSP analysis with the LTP Program. A, Prestimulus DC
baseline, slope and peak amplitude of a model response. B, Representative
fEPSP obtained from hippocampal slice resting on an interface chamber. The
response is the average of 8 consecutive fEPSP sweeps.
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In experiments investigating the effect of drugs or the induction ofLTP on the slope
of the fEPSP, the test field EPSP size was adjusted to approximately 50 % of
maximum (maximum being defined as when a population spike began to appear
superimposed on the fEPSP). Slope of fEPSPs was set to measure 20-80% of the
peak in all experiments and throughout acquisition as described in Anderson and
Collingridge, 2001. Posthoc analysis was only carried out when I was not present
throughout the experiment and hence I had to re-analyse the experiment to make sure
it was done properly.
2.4. Stimulation
The Schaffer collateral-commissural fiber input (or the septohippocampal cholinergic
input to CA1 pyramidal neurones were orthodromically stimulated using bipolar
stimulating electrode(s) which were placed on the surface of the slice in stratum
radiatum and oriens respectively. The stimulating electrodes consisted of two 50 pm
diameter Formvar insulated nickel-chromium (80 %: 20 %) wires (Advent Research
Materials Ltd., England) twisted together and cut at the end to provide focal
stimulation. Stimuli were produced by constant voltage or constant current isolated
stimulator boxes (Digitimer, England) in turn stimulated by a 5V pulse produced by
the PC and relayed via the Digidata 1200. In every series of experiments stimuli
comprised square-wave pulses (200 ps; 0-100 V) delivered homosynaptically at a
fixed intensity every 15-30 s for ionotropic glutamate and GABA receptor-mediated
responses (and every 5-10 min for mAChR-mediated responses).
2.5. Slice & Cell Selection Criteria
For both intra- and extracellular recordings slices were chosen that evoked only a
single population spike to a low frequency stimulus (0.033 Hz) in standard ACSF.
This was taken as an indicator for healthy synaptic inhibition. For intracellular
recordings the input resistance of the cell was greater than 30 measured as
described in section 2.6 below. Action potentials overshot 0 mV and the cells
exhibited some degree of SFA (an accommodation of action potential firing when a
positive current step e.g. + 0.3-0.5 nA, 300ms was applied to the cell). In all
experiments, care was taken that both the recorded response and the passive
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membrane properties of intracellularly recorded neurones were stable for a period of
10-15 min before any physiological or pharmacological protocol was employed.
2.6. Experimental Design
For all LTP experiments, 4-8 field EPSPs were averaged together in a two-minute
period. A 20-minute stable baseline comprised of successive field EPSP slopes that
differed by no more than 15 %. At this point, a high frequency LTP induction
protocol was delivered to the slice and the recording of EPSPs was continued for 1-4
h depending on the protocol employed. Some control dual pathway experiments were
performed in random order, where one pathway was tetanised and one not to ensure
that the two pathways were independent.
All data obtained from transgenic mice, contained in this thesis, were performed
blind to the genotype of the mice and both the design of the experiments and the way
data were handled and analysed were discussed and agreed before the start of each
study. Care was taken to exclude any data obtained when deviations from the agreed
procedure were noted. Some experiments were supervised by a senior member of the
group, on the day, without prior warning to ensure that any such deviations did not
occur.
A randomnised list of mice to be used was made by the animal house technician and
kept in the animal house in a safe place. This list, which comprised interleaved wild-
type and transgenic mice for each day, was not given to me until the end of each set
of experiments, so that the final stages of analysis could be performed. Each
individual experiment was analysed on the day the recording was performed and
pooled data were only drawn at end of each set of experiments. Subsequently, the
analysis of both pooled and individual experiments included were double-checked by
a senior member of the lab group then and also before the data were submitted for
publication and/or for thesis write-up. Data were backed up then and copies were
kept by me and also by the senior member of the group who supervised the analysis
of the data. Should genotyping was needed posthoc, to ensure that numbers enlisted
corresponded to the correct mouse, the tails of each mouse sacrificed were kept in a
labeled eppendorf tube with the date of the experiment at -80°C.
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In intracellular recordings, during the period between stimuli, the input resistance
and the extent of SFA of each neurone were measured routinely using 300-600 ms
long negative and positive current steps (± 0.1-0.4 nA), respectively. In all
experiments sub-threshold stimulation induced reductions in SFA, were evoked,
baseline recordings comprised reductions in SFA, that were consistent over 20-30
min, respectively. In all experiments where the effects of drugs on Vm were assessed,
stable baseline recordings, where the Vm and input resistance of the cell varied no
more than 1 mV and 10 % respectively over a period of 10-30 min, were obtained
prior to application of the drug. In other experiments, where it was required to
compare the EPSPs evoked in the presence and absence of a drug at the same Vm,
DC was injected through the electrode to compensate for any drug-induced changes
in membrane potential. In the sets of experiments where the effect of drugs was
assessed, control and galanin-treated recordings were interleaved in slices obtained
from the same rat. If more than one recording of the same treatment was obtained per
rat, then data were pooled together, so that final n values corresponded to recording
per rat, rather than per slice.
2.7. Analysis ofData
Analysis of intracellularly recorded responses usually comprised the measurement of
the peak amplitude or the slope of the rising phase of the recorded response
(extracellular flEPSPs). The synaptic responses analyzed were single responses in the
case of mAChR-mediated responses. Average responses were used to reduce noise
and mean the effects ofbiological variation for all other types of responses.
The data-handling software package Sigmaplot (Version 2.01, 3.01 & 5.0; Jandel
Scientific, USA) was run on an IBM PC (Dell) and was used to generate plots for
individual experiments and plots of means. Pooled data are presented as means ±
standard error of the mean (S.E.M.) and statistical significance was assessed using a
paired or unpaired Students' /-test performed on raw data with P < 0.05 being taken
as indicating statistical significance, n values refer to the number of times a particular




Along with electrophysiological recordings, some slices were cut in thinner sections
(of 80 pm) and were Nissl-stained to visualise the layered structure of the
hippocampus. Following dissection, some slices were stored in 10% formalin and
stored at 4°C for up to 4 days, when they were transferred to 20% sucrose solution
and stored overnight. The following day they were placed in a shallow petri dish
containing 70% alcohol and simultaneously frozen and cut into 50pm sections using
a cryostat (Leitz Wetzlar, 1310 Germany). Then slices were washed in Tris-buffered
saline (TBS; 0.05M, pH 7.4) and incubated overnight at 4°C with % avidin-
biotinylated horseradish peroxidase complex (ABC, Vector Laboratories).
Then sections were mounted on gelatinised slides and left to dry overnight at room
temperature and then slides went through a cycle of washes in alcohol of different
concentrations to dehydrate and later to remove excess cresyl violet stain, as follows:
90% ethanol, 100% ethanol, xylene, 100% ethanol, 90% ethanol, 70% ethanol, 50%
ethanol, distilled water, 50% ethanol, 70% ethanol, 90% ethanol, 100% ethanol,
xylene. Slides were then coverslipped and allowed todry overnight. Stained sections
were viewed under low power dissection microscope and photographed (see Chapter
1, Huntley & Jones, 1991).
2.9. Drugs
Drugs were stored frozen in stock aliquots (100 pi to 5 ml) of 100 to 10000 times
final concentration and dissolved in ACSF, de-ionised water, or a-dimethyl
sulphoxide (DMSO) (Sigma, UK). All drugs were added to the control ACSF and
administered by bath perfusion for at least 15 min to allow their full equilibration
within the slice. Atropine, Ach and picrotoxin were purchased from Sigma (Poole,
UK). 6-nitro-7-sulphamoylbenzo[/]quinoxaline-2,3-dione (NBQX), were purchased
from Tocris Cookson Ltd. (Bristol, UK). Galanin, galanin receptor active ligands
Ml 5, M40 and C7 were purchaced from Sigma. All protein kinase inhibitors, like
Calphostin C (PKC inhibitor), KT5823 (PKG inhibitor), K-252b (mainly for
inhibition ofPKA) and H-7 (non-specific; primarily used to target PKC) were bought
by Sigma.
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D-(£)-2-Amino-4-methyl-5-phosphono-3-pentanoic acid (CGP 40116) and [1-(<S)-
3,4-dichlorophenyl)ethyl]amino-2-(iS)-hydroxypropyl-p-benzyl-phosphonic acid
(CGP 55845A) were gifts from Ciba-Geigy Ltd. (now Novartis; Basel, Switzerland)
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CHAPTER 3
CHARACTERISATION OF THE EFFECTS OF GALANIN ON
BASAL SYNAPTIC TRANSMISSION AND SHORT-TERM
SYNAPTIC PLASTICITY IN THE CA1 AREA OF THE
HIPPOCAMPUS IN RATS
3.1. Introduction
In this chapter, I show that exogenous galanin application caused an increase in basal
synaptic transmission of glutamate receptor mediated fEPSPs recorded in the CA1 of
rat hippocampal slices, which appeared to be dose-dependent (Figures 3.1. and 3.2.).
The aforementioned effect was not seen when recordings were performed in CA3-
ectomised slices (Figure 3.2). Figure 3.3. shows that galanin (100 nM) did not have
any significant effect on PPF in slices that retained the CA3 area intact. Because that
was the case, I decided to perform a positive control experiment in CA3 containing
slices, to show that doubling the concentration of calcium in the external medium did
produce a significant reduction in PPF, only at 25 ms interstimulus intensity (Figure
3.4). Perfusion of galanin at the concentration, which causes a significant effect on the
slope of the flEPSPs (300 nM) had a similar effect on PPF (Figure 3.5) only apparent
at interstimulus interval of 25 ms. In conclusion, galanin may cause an enhancement of
synaptic transmission by activating galanin receptors located in presynaptic neurones
originating in the CA3 area and which synapse to pyramidal cells in the CA1 area.
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3.2. Results
3.2.1. Galanin enhances basal synaptic transmission in the CA1 area of
hippocampus in rats
First, I wanted to test the effect of exogenous galanin perfusion on the slope and
amplitude of the fEPSPs generated by low frequency stimulation of the en passage
synapses of the CA3 Schaffer collateral commissural pathway onto basal and apical
dendrites in the CA1 area. All drugs were perfused for at least 20 minutes until the
slope and amplitude of fEPSPs were stable. Recordings were made for at least 40
minutes following the addition of any drugs.
In Figure 3.1, the pooled data from the complete study are presented where the effect
of porcine galanin (100-1 pM) was found to be dose-dependent in stratum radiatum
and oriens. As shown in figure 3.2.A, 300nM porcine galanin induced a significant
increase in the slope of fEPSPs in eight experiments. More specifically, and measuring
the percentage baseline change of the last point of each set of experiments perfusion
of lOOnM galanin had a non significant effect on the fEPSP slope (103+3% SEM,
n=8), whereas 300nM, 1 pM and 3 pM induced an increase in fEPSP slope
amounting to 145+2, 174+3 and 187+5 % SEM respectively. The same experiment
was repeated for field responses obtained during low frequency stimulation of CA3
collateral commissural fibres ending on the basal dendrites of stratum oriens and the
pooled data are shown in Figure 3.2 .B. In eight experiments, concentrations of galanin
of 300 nM, 1 pM and 3 pM induced increases of fEPSP slope amounting to 147+/-3,
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Figure 3.1. Galanin enhances the slope of fEPSPs in a dose-dependent manner in the CA1,
where A, shows the effect of 100 nM to 3 pM in stratum radiatum and B, in stratum oriens.
Sample traces are shown from a recording in stratum radiatum prior to (black traces) and
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Figure 3.2. High concentration of galanin (300 nM) enhances basal synaptic transmission only
in slices with the CA3 intact, the graphs represent pooled data from recordings performed in
stratum radiatum (panel A) or oriens (panel B), where 300 nM galanin caused a significant
increase in the slope of fEPSPs in slices with the CA3 area intact, compared to synaptic
transmission in CA3-hemisected slices (n=8,8 for both sets of recordings). The traces are
example waveforms (average of 8) recorded from intact slices prior to and following the






3.2.2. The effect of galanin on PPF ratio
PPF is measured as the ratio of the rising slope of the second fEPSP to the rising
slope of the first fEPSP. PPF is a short lasting presynaptic alteration in synaptic
efficacy, where a high and low PPF ratios indicate low and high release probability,
respectively (Bekkers & Stevens, 1990; Deupree et al., 1993; Manabe & Nicoll,
1994). The investigation of the effect of galanin on paired-pulse facilitation was the
basis of the next experiment, because I wanted to test the hypothesis that galanin at
300 nM caused an enhancement of presynaptic excitability, thereby producing an
increase in the slope of fEPSPs in the CA1 and then I wanted to check whether if
indeed that was the case this effect depended on the slice being intact or not.
Galanin was dissolved to make 100 mM and 300 mM stock drug aliquots and was
kept at - 80°C, with a separate batch of vials, which contained ACSF (vehicle). Stock
dilutions were made by a lab partner, who was not involved in my project and were
colourcoded by him. I performed this experimental protocol blind. The protocol
consisted of acquiring a fEPSP in the CA1 area and obtaining a stable baseline of
FEPSPs in response to a single shock at low frequency stimulation (@30 s). Two
consecutive shocks at 25 and 50 ms were interleaved for 4 sweeps just before adding
the drug, 20 minutes following the addition of the drug and 20 minutes following the
start of the washout.
Figure 3.3. summarises the finding of recordings performed in intact slices using 100
nM galanin. Exogenous galanin (100 nM) had no significant effect on the PPF ratios
in either interpulse intervals in the CA1 area (n=6; P>0.05). Figure 3.4. show the
results of a positive control experiment, in which I raised the concentration of external
calcium from 2mM to 4mM to check whether indeed that reduced significantly PPF (n
= 6, P<0.05) and which interstimulus interval (25 ms). Finally, Figure 3.5. contains
pooled data in graphical representation from 6 epxeriments in which perfusion of 300
nM galanin caused a siginificant reduction in PPF at 25 ms only in intact slices
(P<0.05), but not in CA3-hemisected slices (n=6, P>0.05).
73
B 2.0




Control 100 nM Galanin Washout
Figure 3.3. Low concentration of galanin (lOOnM) has no significant effect on paired pulse
facilitation in the CA1 area. A, representative traces of field recordings obtained during control
(black traces)/vehicle (red = 25 ms; blue = 50 ms) and galanin-treated (red = 25 ms; blue = 50
ms) conditions, showing the responses following PPF stimulation protocol with interstimulus
interval of 25 ms and 50 ms. Each trace is the average of four trials. B, Pooled data in
graphical format of six recordings obtained from intact hippocampal slices, where black bars
denote 25 ms and grey bars 50 ms interstimulus interval. There was no significant difference
between the control and galanin-treated groups (n=6; Student's t-test, P>0.05). Values are
means ±S.E.M. represented by the error bars.
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Figure 3.4. High external calcium concentration (4mM) causes a reduction in PPF ratio. A,
Representative waveforms (average of 4 consecutive trials) for each of the interstimulus
intervals tested (black traces = 25 ms and red traces = 50 ms) and B, pooled data for 6
experiments showing that in intact slices alteration of external calcium from 2 mM to 4 mM
causes PPF to drop significantly (Student's t-test, P<0.05) for the 25 ms interstimulus interval
(black bars), but not for the 50 ms interstimulus interval.
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Figure 3.5. High concentration of galanin (300 nM) causes a reduction in PPF ratio. A,
Representative waveforms (average of 4 consecutive trials) for 25 ms interstimulus interval
tested and B, pooled data for 6 experiments showing that in intact slices (black bars) galanin
causes PPF to drop significantly (Student's t-test, P<0.05), but not in CA3-hemisected slices
(grey bars).
20 ms




In this chapter, I demonstrated that, galanin causes a significant increase in the slope
of fEPSPs in a dose-dependent manner. Although this effect was seen when galanin
was perfused at 300 nM, it was not observed at the lower concentration of 100 nM.
Moreover, this effect appeared to be dependent on the CA3 area being intact, because
it was not observed in recordings obtained from CA3-hemisected slices.
Interestingly, galanin at a 300 nM concentration also caused a significant reduction in
PPF (25 ms interstimulus interval). This leads me to conclude that galanin may act
presynaptically to either block potassium channels or activate a voltage-gated calcium
channels, thereby causing an alteration in the excitability of neurones projecting from
the CA3 area to CA1. This finding does not preclude the dual action of galanin on
both pre- and postsynaptic galanin receptors in the hippocampus. A dual differential
effect on pre— and postsynaptic sites could explain my finding described in Chapter
4, that galanin at the lower concentration of 100 nM significantly inhibits LTP in the
CA1.
The presynaptic modulation of neurotransmitter release by galanin is not a novel
physiological observation. Indeed, the way galanin might act to modulate
acetylcholine is by acting on presynaptic receptors in cholinergic terminals or
postsynaptic receptors on smooth muscle modifying the biochemical cascade initiated
by acetylcholine acting through Mi receptors. Mi receptors are believed to act via a
G-protein coupled receptor to decrease potassium conductance, thereby causing
membrane depolarisation in nerve cells (Goyal, 1989). Interestingly, galanin was
found to inhibit the twitch contractions of longitudinally and circularly oriented
muscle strips mediated by the stimulation of cholinergic neurons in the guinea pig
ileum (Botella et al., 1992), but not the contractions mediated by direct stimulation of
smooth muscle cells with carbachol. The inhibitory effect of galanin was antagonized
by galantide and did not appear to affect other neurotransmitter effects, like of
noradrenaline or GABA. As such, it seems that galanin inhibits the motility of guinea
pig ileum by inhibiting acetylcholine release from the enteric cholinergic neurons,
77
probably through the specific receptor located on soma-dendritic regions and nerve
terminals of cholinergic neurons (Kuwahara et al., 1988; Akehira et al., 1995; Botella
etal., 1995, Kakuyama et al., 1997).
In the pancreas, galanin inhibits insulin release by either activating a potassium
channel or inhibiting a voltage sensitive calcium channel, the reverse mechanism of
what might be happening in my slices and indeed galanin has been shown to reduce
the release of excitatory amino acids in the hippocampus by the same mechanism (Zini
et al., 1993). Previous studies have demonstrated that bath applied galanin resulted in
a slight hyperpolarisation of the membrane potential in CA1 pyramidal cells without
any changes in input resistance (Dutar etal., 1989). Galanin did have an effect on
electrically evoked responses. Excitatory amino acid mediated neurotransmission at
Schaffer collateral-CAl synapses was slightly reduced by galanin. However, it was the
inhibition of an atropine-sensitive long lasting depolarisation by galanin that proved of
major interest. Galanin did not show any effect on responses to exogenously applied
ACh suggesting a presynaptic inhibition of galanin on ACh-releasing nerve terminals.
This result is consistent with several studies of galanin regulation of ACh release and
ACh-dependent functions in the hippocampus (Fisone et al., 1987; Palazzi et al., 1988
&1991). Finally, a more recent study has shown that a G; (pertussis-sensitive) coupled
galanin receptor (GalRl) mediates the inhibition of acetylcholine release in the rat
cerebral cortex, probably by the same mechanism as it does in the gut (Wang et al.,
1999; Branchek et al., 2000).
What I show here need not, however, contradict all previous published findings.
Indeed, in conditions other than high frequency firing, such in form of short-term
plasticity e.g. the PPF paradigm, galanin may act as as a potassium channel blocker
presynaptically, thereby altering the K+/Ca2+ dynamics in the terminal and activating
voltage-gated Ca2+ channels thus increasing glutamate (Zini et al., 1993) or
acetylcholine release (Wang et al., 1999; Ogren et al., 1998 & 1999). The enhanced
glutamate release activates postsynaptic AMPA receptors, thereby leading to an
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increase in postsynaptic excitability that may alleviate the Mg2+ blockade of the
NMDA receptor.
Although, GALR3 mRNA is not expressed in the hippocampus (Smith et al., 1998;
Kolakowski et al., 1998; Wang et al., 1999), a presynaptic action of galanin is further
corroborated by the expression of galanin receptors (GALR2) in the presynaptic
terminals of cholinergic neurons projecting from the septum to the hippocampus in
rodents (Ogren et al., 1998). Although this has not yet been shown, I cannot exclude
the possibility that GALR2 is also expressed on the presynaptic terminals of
glutamatergic neurons, thereby directly modulating glutamate release (Zini et al.,
1993) at high frequency stimulation paradigms.
Exogenously applied galanin inhibits synaptically evoked cholinergic responses in
CA1 pyramidal cells according to several reports regarding the inhibition of ACh
release by galanin (Dutar etal., 1989; Fisone et al., 1987; Palazzi etal., 1988, 1991).
Moreover, it has been proposed that this effect may also be also mediated by a
presynaptic galanin receptor. It is likely that this effect is mediated by the Gi/0 coupled
GALR2 as mRNA for this receptor is apparent in the ventral hippocampus where the
inhibition of ACh release is observed. GALR2 is also expressed in the dentate gyrus
of the dorsal hippocampus and may be responsible for increased ACh release in the
awake rat, while GALR1 mRNA is found in hippocampal neurons and the receptor is
thought to be expressed postsynaptically (Ogren et al., 1998).
79
3.5. Future Experiments
To reverse the effects of galanin one may consider using galantide, which has been
shown to antagonise galanin in a variety of preparations (Lindskog et al., 1992,
Reymann et al., 1994; Takahashi et al., 1994; Mahns & Courtice, 1996; Selve et al.,
1996). However, galantide has been known to have a controversial action of, for
example in some preparations it has been shown to be a weak agonist of GalRl
(Ceresini et al., 1998; Gu et al., 1993, Wang et al., 1999). It could be useful to repeat
some of these experiments using other more selective galanin antagonists to attribute
the effects of the neuropeptide to specific receptor subtypes.
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CHAPTER 4
THE EFFECTS OF GALANIN ON LONG-TERM SYNAPTIC
PLASTICITY IN THE CA1 AREA OF RODENT HIPPOCAMPUS
4.1. Introduction
This section covers the basic information relevant to the rest of the chapter. A more
detailed account on the cellular mechanisms of synaptic transmission and plasticity is
laid down in Chapter 1 of this thesis. In brief, long-term synaptic plasticity of
glutamate-mediated synaptic transmission in the hippocampus is believed to be an
important process for learning and memory in vertebrates (Bliss & Collingridge,
1993). In particular, those forms of long-term synaptic plasticity that are NMDA
receptor dependent (e.g., LTP and LTD) are thought to be particularly important for
these processes. To induce LTP and LTD requires the appropriate integration of
GABAergic inhibitory and glutamatergic excitatory synaptic inputs (Davies &
Collingridge, 1993).
However, in addition to amino-acid mediated synaptic transmission each area of the
brain, which supports LTP or LTD, also receives a variety of non amino-acid
mediated synaptic inputs. These may have the capacity to either promote or restrict
the induction of long-term synaptic plasticity (Blitzer et al., 1990; Bliss &
Collingridge, 1993; Edagawa et al., 2000). Thus, for example, the CA1 region of the
rodent hippocampus receives the septohippocampal projection, amongst others,
which is a heterogeneous population of afferents capable of releasing
neurotransmitters such as ACh, 5-HT and various neuropeptides into the
hippocampus (Decker & McGaugh, 1991; Dutar et al., 1995). A detailed account of
the anatomy and physiology of the septohippocampal projection is laid out in
introductory section 1.3.3.
Each of these afferents specifically targets distinct populations of cell types that
differentially influence the behaviour of individual pyramidal cells or interneurones.
Consequently, each afferent can directly or indirectly affect synaptic transmission
and plasticity in the hippocampal CA1 region. As such, cholinergic innervation
through depolarization of pyramidal neurones (Cole & Nicoll, 1983, 1984; Morton &
Davies, 1997), activation of intracellular biochemical cascades (Dutar & Nicoll,
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1988b) and inhibition of GABA release (Freund & Buszaki, 1996; Manuel & Davies,
1998) can strongly promote the induction ofLTP (Auerbach & Segal, 1994; Blitzer
et al., 1990). Whilst the effect of the primary neurotransmitters, such as ACh and 5-
HT, on LTP have been extensively studied, investigation of the effects of co-released
neuropeptides have attracted less attention.
Here, I have attempted to address how galanin, one of these neuropeptides (Tatemoto
et al., 1983; Palazzi et al., 1991; Kask et al., 1995), affects LTP and LTD. The
reason for choosing this particular twenty-nine amino-acid neuropeptide (Bedecs et
al., 1995) is that it is co-localised with ChAT in 30-35% of medial septal and basal
forebrain vertical VLDB cholinergic afferents (Melander et al., 1985; 1986; Crawley
& Wenk, 1989; Gaykema et al., 1991) innervating the hippocampus. Furthermore,
selective lesion of cholinergic afferents and exogenous application of galanin
(McDonald et al., 1997) impair spatial learning tasks for which LTP and LTD are
believed to form part of the synaptic basis (Bliss & Collingridge, 1993). In summary,
what I have found and am presenting in this chapter is that galanin inhibited LTP, but
not LTD, irrespective ofwhether this was induced by tetanic or theta-burst
simulation, in both stratum radiatum and oriens of the area CA1 in the rat
hippocampus (Figures 4.2, 4.3, 4.4 and 4.12). The degradatory effect of galanin on
tetanically induced LTP was dose-dependent (Figure 4.1) and was reversed by the
galanin antagonist, M15 (Figures 4.13 and 4.14). Furthermore, galanin did not affect
isolated NMDA EPSPs or Group I metabotropic glutamate receptor effects in the
CA1, thereby rendering the probability of the neuropeptide exerting its effect on LTP
via the NMDA or mGluR receptor system, slim (Figures 4.5, 4.6, 4.7 and 4.8).
However, galanin impaired phorbol ester (PDBu) induced potentiation of synaptic
transmission, which suggests that it may act to inhibit LTP by interfering with PKC
activity (Figures 4.11). A proportion of these data have been reported previously in




4.2.1. Galanin inhibits tetanus-induced long-term potentiation in stratum
radiatum
In a first series of experiments, described in more detail in Chapter 3,1 attempted to
establish whether galanin affected glutamatergic synaptic transmission at apical
dendrites in area CA1. Perfusion of galanin (lOOnM - 1 pM) did not affect baseline
fEPSPs per se recorded in stratum radiatum in response to stimulation in the same
dendritic field, in CA3 ectomised rat slices (Figure 3.2, n=8; P>0.05). Subsequent
afferent tetanization at 100 Hz for 1 s, in the continued presence of galanin at
concentrations greater than 10 nM, resulted in a short-lasting potentiation, which
decayed back to baseline over the course of the next 20-30 minutes. In contrast, in
naive slices the same tetanization protocol resulted in a robust LTP that was
maintained throughout the recording period (Figure 4.1/1; ANOVA, P<0.05). As
such, in galanin (100 nM)-treated slices the magnitude ofLTP measured 30 minutes
post-tetanus was only 110 ± 8 % (n = 8) as compared to 152 ± 15 % SEM in control
slices (n = 8). Figure 4.1. shows the dose-dependent effect of galanin on LTP and
Figure 4.2 presents a more detailed account of single experiments and pooled data
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Figure 4.1. The effect of galanin on LTP is dose-dependent regardless of whether recordings
were made stratum radiatum or oriens. This is a summary data for tetanus-induced LTP
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Figure 4.2. Galanin impairs the induction of LTP in stratum radiatum of the CA1 area following
tetanus stimulation. A, Two sets of synaptic traces representing superimposed fEPSPs recorded
prior to and 30 minutes following delivery of a 100 Hz for 1 s tetanus in the absence (top) and in
the presence of 100 nM galanin (bottom left hand traces). The two graphs are plots of the slope
of the fEPSP, normalized with respect to the 20-minute baseline immediately preceding the
tetanus, versus time, in the absence (top panel) and presence of 100 nM galanin (bottom panel)
obtained from individual dual pathway recordings. Each experiment includes a non-tetanised
(open circles) and a tetanised pathway (closed circles). B, The graph is a plot of the mean ±
S.E.M. of the fEPSP slope, normalized in the same way as the individual experiments shown
above, versus time, in the absence (red circles) and presence (black circles) of galanin. Galanin
application began IS minutes prior to tetanization and persisted up until 10 minutes post-
tetanus and induced a significant impairment on LTP (ANOVA, P<0.05). Each point is the
average slope measurement obtained from four successive responses, obtained over a 2-minute
period, and has been pooled across 8 experiments in each case.
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4.2.2. Galanin inhibits theta-induced long-term potentiation in stratum radiatum
Since (1) LTP can be induced by a number of distinct stimulation protocols (Davies
& Collingridge, 1993; 1996) and (2) LTP induced by each of these protocols may be
differentially influenced by distinct pharmacological treatments (Davies et al., 1991;
Seabrook et al., 1997) I chose to perform a second series of experiments to establish
the effect of galanin on LTP induced by a theta-burst tetanus (i.e. 5 bursts of four
stimuli at 100 Hz delivered at intervals of 200 ms). As with tetanic stimulation,
galanin (100 nM) inhibited LTP induced by theta-burst tetanic stimulation in stratum
radiatum (n = 8; Figure 5.1.8, ANOVA, P<0.05). Thus, in galanin-treated slices the
magnitude ofLTP measured 30 minutes post theta-burst was only 108 ± 9 % (n = 8)






































Figure 4.3.Galanin impairs the induction of LTP in stratum radiatum of the CA1 area following
theta-burst stimulation. This is a replica of Figure 4.1. showing that 100 nM galanin perfusion
induces a significant impairment of LTP (ANOVA, P<0.05).
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4.2.3. Galanin inhibits long-term potentiation in stratum oriens
Galanin receptor binding is generally higher in stratum oriens than in stratum
radiatum (Dutriez et al., 1996). As such, I addressed next whether galanin also
inhibited LTP in basal dendrites. As illustrated in Figure 4.2/4, 100 nM galanin
produced an almost identical profile of inhibition of LTP in stratum oriens to that in
stratum radiatum. Thus, for 100 Hz for 1 s tetanic stimulation, the magnitudes of
LTP measured 30 minutes post-tetanus in the presence and absence of galanin in
stratum oriens were 107 ± 9 % (n = 7) and 140 ±11% SEM (n = 9) (Figure 4.3,
ANOVA, P<0.05), respectively compared with 110 ± 8 % (« = 8) and 152 ±15 %(n
= 8) for stratum radiatum (Figure 4.4).
4.2.4. Mechanism by which galanin inhibits long-term potentiation
Thus, galanin was clearly capable of inhibiting LTP; but the mechanism by which
this occurred was yet unknown. A striking feature of the short-term potentiation
induced by both 100 Hz for 1 s and theta-burst tetanic stimulation in the presence of
galanin is its marked similarity to that induced by stimulation paradigms that weakly
activate the NMDA receptor system (Abraham & Bear, 1996). As such, I addressed
the possibility that galanin may restrict NMDA receptor activation to a level that may
be subthreshold for inducing LTP. Initially, I compared the envelopes of synaptic
potentials evoked by both tetanic and theta-burst stimulation paradigms in each
dendritic field in control medium with those evoked in the presence of galanin. This
analysis revealed no substantial differences between any of the pairs of responses
compared, indicating that changes in NMDA receptor function were unlikely to
account for the inhibition ofLTP in either stratum radiatum or oriens (Figures 4.5
and 4.6).
To further substantiate this, I tested the effect ofgalanin on isolated NMDA receptor-
mediated fEPSPs recorded in the presence of 5 pM NBQX, 50 pM picrotoxin and 1
pM CGP 55845A to block all AMPA/kainate, GABA^ and GABAg receptor
activation, respectively. As illustrated in Figure 4.7, galanin had no significant effect
on the peak amplitude (Student's t-test, P>0.05) or duration of pure NMDA receptor-
mediated fEPSPs. To assess statistical significance on the duration ofNMDA
receptor mediated fEPSPs the area under each waveform prior to and following the
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addition of galanin was measured and the results were averaged to 83 ± 13 and 101
± 20 for 5 experiments.
Another possibility for why galanin inhibits LTP is that galanin affects the activation
of mGluRs since antagonists of these receptors have been shown to limit post-
conditioning stimulation potentiation to a short-term potentiation lasting 20-50 mins
(Bashir et al., 1993; Breakwell et al., 1996). To test whether galanin inhibited
mGluR function I examined whether galanin affected the increase in cell input
resistance and reduction in spike frequency adaptation that was induced by the
selective mGluR agonist (IS, 3R)-ACPD (10-50 pM) (Breakwell et al., 1996). In all
experiments performed, galanin did not significantly affect any of the responses
evoked by this agonist (Figure 4.8.A; n = 5). The way I analysed my results was
intially qualitative, by measuring number of spikes prior to and following the
addition of galanin for 5 cells (control, trans-ACVT.), plus lOOnM galanin; n=2.9±0.1,
6.6±0.18, 6.7±0.2 SEM). Subsequently, I used a quantitative method, by calculating
the interspike intervals (control, trans-ACPD, plus lOOnM galantine; n=2.5±0.2,
13.9±2.3, 12.9+2.5 SEM). No significant difference was noted in the measurements
prior to and following the addition of galanin (Student's t-test, P>0.05). See also
Figure 4.8.5 provided to show that under galanin does not affect firing properties of
the cell if applied before (IS, 3R)-ACPD (n=4, Student's t-test, P>0.05).
As a result of these negative experiments I turned my attention away from the
receptor systems involved in the induction of LTP in favour of an investigation of
mechanisms further downstream of receptor activation that convert STP into LTP.
As such, I initially examined whether galanin was capable of inhibiting the
expression of pre-established LTP to enable me to pinpoint the type of biochemical
processes that it may be affecting. In two sets of experiments, galanin was found not
to affect LTP when applied either 20 or 60 minutes after delivery of a 100 Hz for 1 s
tetanus (Figure 4.9). This pointed to a possible interaction between galanin and
kinase activation since many kinase inhibitors have been shown to be effective in







































Figure 4.4. Galanin inhibits the induction of tetanus induced LTP in stratum oriens of area CA1.
This figure is a replica of Figure 4.1. for this experiment showing that 100 nM galanin induced a
significant impairment in LTP (ANOVA, P<0.05) in a total of 8 pooled experiments for each








Figure 4.5.GaIanin does not affect extracelluraly recorded synaptic responses evoked by either
A, tetanic or B, theta-burst stimulation in stratum radiatum. Superimposed traces of the
respective envelopes are shown in each case, where black traces denote the responses recorded
in control medium, while red traces the responses recorded in 100 nM galanin. Pooled data of 8
traces for each stimulation paradigm show no significant effect of galanin on the area under the





Figure 4.6. Galanin does not affect extracelluraly recorded synaptic responses evoked by either
A, tetanic or B, theta-burst stimulation in stratum oriens. Superimposed traces of the respective
envelopes are shown in each case, where black traces denote the responses recorded in control
medium, while red traces the responses recorded in 100 nM galanin. Pooled data of 8 traces for
each stimulation paradigm show no significant effect of galanin on the area under the
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Figure 4.7. Galanin does not affect NMDA receptor function. A, shows, from left to right,
synaptic traces evoked by a burst of four stimuli delivered at 100 Hz in control medium, in the
presence of a cocktail of AMPA, GABAa and GABAb receptor antagonists, in the additional
presence of 100 nM galanin, following washout of galanin and after subsequent application of
the NMDA receptor antagonist CGP 40116. The graph below these traces is a plot of the peak
amplitude of the composite fEPSP throughout the period of the experiment. In B, synaptic
traces prior to and following application of galanin depicted in A, are shown superimposed.
Galanin had no statistically significant effect neither on average peak amplitude nor on duration
of NMDA receptor mediated fEPSPs (Student's t-test, P>0.05).
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Figure 4.8. Galanin does not affect metabotropic glutamate receptor function. In A, traces are
intracellular recordings of the membrane potential response of a CA1 pyramidal neurone to
intracellular injection of a depolarising current step (+0.3 nA) illustrating the loss of spike
frequency adaptation induced by (1S,3R)-ACPD and the lack of effect of galanin on this
response. Quantitative measurement of spike frequency adaptation revealed no statistically
significant difference prior to and following galanin application (n=5; Student's t-test, P>0.05),
while SFA was significantly reduced by perfusion (1S,3R)-ACPD (n=5; Student's t-test, P<0.01).
In B, the bottom set of figures is another cell, where the same experiment was repeated, with
galanin added before (IS, 3R)-ACDP to ensure that it does not affect the firing of spikes (n=4;
Student's t-test, P>0.05).
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conditioning stimulation but not thereafter (Malinow et al., 1989; Grant & O'Dell,
1994). Indeed, in my own hands, we have been able to demonstrate that in the
presence of kinase inhibitors such as 1 pM KT5823 (protein kinase G inhibitor),
K252b (PKC inhibitor) and calphostin C (inhibitor of PKC, PKA and myosin light
chain kinase) tetanic stimulation that normally induces LTP induced only STP
(Figure 4.10).
However, to demonstrate conclusively that galanin is restricting kinase activity
required for LTP is a particularly problematic issue to address experimentally since
(1) LTP is synapse-specific (Bliss & Collingridge, 1993) and, therefore, biochemical
modifications are highly restricted to the small number of synapses undergoing LTP
and (2) it is still unclear what the precise biochemical cascades that account for
conversion of STP into LTP are. Nevertheless, to establish whether galanin could
inhibit electrophysiological consequences of protein kinase activation we examined
whether galanin was capable of inhibiting electrophysiological effects of phorbol
esters that activate protein kinase C. In eight experiments, a 20 minute application of
phorbol dibutyrate (10 pM) potentiated the initial slope of fEPSPs (Malenka et al.,
1986) such that the magnitude of the potentiated fEPSP slope amounted to 281 ±11
% of the baseline control slope. This effect was partially inhibited by 100 nM galanin
(n = 8; Figure 4.11), such that the phorbol dibutyrate enhancement in the presence
this neuropeptide amounted to only 192 ±17 % of control; representing a 63%
reduction in potentiation.
These data pointed towards a negative interaction between galanin and kinase
activity as a potential explanation for the restricted expression ofLTP in the presence
of this neuropeptide. If this hypothesis was correct, it might be expected that galanin
should not affect synaptic plasticity that is not highly dependent upon activation of
kinase activity, and instead is critically dependent upon phosphatase activity (Bear &
Malenka, 1994). As such, I tested next the ability of galanin to restrict the induction
of long-term depression in area CAl. In eight experiments, LTD was induced in
stratum oriens using a low frequency stimulation paradigm comprising 900 shocks
delivered at 2 Hz. Galanin (100 nM) did not significantly affect the magnitude or
temporal profile of this LTD (Figure 4.12). Thus, the slope of the fEPSP measured
20 minutes after the conditioning stimulation in galanin treated slices was 83 ± 5 %
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Figure 4.9. Galanin does not affect the maintenance of LTP. A, Graphical representation of two
individual recordings, where galanin was applied 20 minutes (open circles) and 60 minutes
(closed circles) post-tetanus. B, Pooled data of the above experiment showing LTP recorded in
stratum radiatum in response to a 100 Hz for 1 s tetanus. The format of the data presented is
identical to that in previous figures except that galanin was applied 20 (n=6) and 60 (n=10)
minutes after tetanization. Note that LTP persisted for the period of the recording. Synaptic
traces are representative example responses taken from one of the pooled experiments
illustrating fEPSPs recorded prior to tetanization, post-tetanization just before galanin
application and post-tetanization just after termination of the galanin application. No significant

































































Figure 4.10. Protein kinases are important in long lasting synaptic potentiation. A is an LTP
graph showing that protein kinase inhibitor Calphostin C prevents the induction of LTP but
still permits a short-lasting potentiation similar to that observed in the presence of galanin. In B,
the bar graph illustrates the magnitude of LTP induced by a 100 Hz for 1 s tetanus in control
medium and in the presence of 1 pM of the protein kinase inhibitors K-252b (n=5), calphostin C


































Figure 4.11.Galanin impairs phorbol-dibutyrate induced potentiation of synaptic transmission.
In A, the superimposed synaptic traces are representative examples of fEPSPs recorded in these
two sets of experiments before PDBu application and 30 minutes afterwards (left panel).
Graphical representation (right panel) of two individual recordings, where PDBu-induced
potentiation (filled circles) is inhibited by coapplication of galanin (open circles). In B, the
graph shows pooled data in a time-dependent plot of the fEPSP potentiation induced by














































Figure 4.12. Galanin does not affect LTD. A, superimposed traces recorded prior to (black
traces) and following (blue traces) a 2 Hz for 7.5 min LTD induction protocol in the absence (left
panel) and presence (right panel) of galanin. On the right, two individual recordings are shown
in graphical representation, where LTD was induced in the absence (filled circles) and the
presence (open circles) of galanin. B, pooled data are shown in a plot of the mean ± S.E.M. of the
slope of the fEPSP in stratum radiatum, normalized with respect to the 20 minute baseline
immediately preceeding the LTD conditioning stimulation paradigm, versus time, in the absence
(closed circles) and presence of 100 nM galanin (open circles). Data points have the same
meaning as described in previous figures. Synaptic traces correspond to representative field
EPSPs recorded prior to and 20 minutes after the period of conditioning stimulation in the
presence and absence of galanin. No statistical significance was observed in recordings prior to
and following the application of galanin (ANOVA, P>0.05).
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4.2.5. Galanin fails to impair LTP in the presence of M15
Next, galanin receptor mixed agonist Ml 5 was perfused on hippocampal slices to
investigate whether it antagonises the effect of galanin on glutamate receptor
mediated synaptic plasticity. As such, in stratum radiatum Ml 5 (1 pM) perfused
with galanin (100 nM) induced an average LTP 151 ± 14 % SEM (n=6), while Ml5
perfused on its own 149 ± 10 % SEM (n-6). Both sets of experiments yielded no
significant difference between LTP recorded in control conditions (Student's t-test,
P>0.05), while they were statistically significant to LTP induced in the presence of
galanin (Student's t-test, P>0.05). There was no significant difference prior to and
following galanin application (ANOVA, P>0.05). In Figure 4.13, LTP graphs
obtained in the presence ofMl 5 on its own (filled triangles, n=6) or in combination
with galanin (open triangles, n=6) are presented, to show that Ml5 when applied
with galanin reverses the degradatory effect of galanin on LTP. Recordings were
performed in apical and basal dendrites and data were pooled together. All
normalised values following tetanic stimulation were averaged and the results for
each drug treatment are presented in graphical format (Figure 4.14). Application of
galanin has a statistically significant impairment on LTP compared to control,
galantide & galanin or galantide applied on its own (ANOVA, P<0.05).
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Figure 4.13. M15 blocks galanin-induced LTP impairment (1).
B 250
0 20 40 60 80
Time (mins)
In A, superimposed traces are obtained form individual tetanus induced LTP experiments in the
CA1 area, where M15 was perfused 10 minutes prior to (black trace, left) and 15 minutes
following tetanic stimulation (green trace, left). The second pair of superimposed traces show a
baseline trace (black, right) recorded in galanin and M15 compared to a trace following tetanic
stimulation (green, right). B,Graphical representation of the effects of galanin inhibitor M15 on
LTP (n=6, ANOVA, P>0.05). When M15 is coapplied with galanin (n=6), then the impairment
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Figure 4.14. M15 blocks galanin-induced LTP impairment (2). Graphical representation of 30
minutes post-tetanus mean of normalised fEPSP slope for control LTP experiments (n=8)
compared to LTP experiments obtained in the presence of M15 (n=6) alone, galanin alone (n=8)
and a coctail of galanin and M15 (n=6). Addition of M15 reverses the significant impairment
induced by galanin (ANOVA, P<0.05).
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4.3. Discussion
The present data confirm previous findings of Sakurai et al. (1996) that galanin
restricts the induction ofLTP in the apical dendrites of CA1 pyramidal neurones. In
addition, here I now showed that galanin inhibits LTP in the basal dendrites of these
neurons. Taking Chapters 4 and 5,1 show that this inhibitory effect of galanin on
LTP is conserved in three species viz guinea pig (Sakurai et al., 1996), rat and
mouse. Furthermore, this effect is independent of the pattern of afferent stimulation
used to induce LTP and is selective for this form of long-term synaptic plasticity in
that LTD is not affected by galanin applied during the conditioning period.
Until now, no formal studies have attempted to address the mechanism by which
galanin restricts the induction ofLTP. In this respect, my study was an innovative
way to address the cellular mechanism by which galanin may inhibit learning and
memory. Consistent with this behavioural effect of galanin, the observations that
galanin (1) does not affect basal synaptic transmission, (2) is effective only when
applied during the period of conditioning stimulation and (3) still permits short-term
potentiation to be expressed in its presence suggests that its mechanism of action is
related to an effect on those cellular processes that are necessary for the induction of
LTP and, more specifically, to those processes that are important for the conversion
of STP into LTP. Relevant to this point, the activity-dependent alterations in
glutamatergic and GABAergic synaptic transmission that are necessary to promote
NMDA receptor activation and the induction ofLTP during tetanic and theta-burst
tetanic stimulation are quite distinct (Davies & Collingridge, 1993, 1996). Illustrating
this point, pharmacological agents that modify GABAergic synaptic transmission,
such as benzodiazepines or GABAb receptor antagonists, inhibit theta-burst induced
LTP but not tetanus-induced LTP (Davies et al., 1991; Seabrook etal., 1997). Thus,
as galanin blocks LTP induced by both conditioning stimuli it would seem unlikely
that its mechanism of action is related to subtle modulation of GABAergic or
glutamatergic synaptic activity.
Indeed, there is little if any evidence to suggest that galanin directly affects transient
activity-dependent changes in either GABAergic or glutamatergic synapses. Instead,
galanin is most likely having its inhibitory effect through a robust inhibition of one
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or more critical LTP inducing mechanisms that are common to both stimulation
protocols.
One such common feature of these different methods of inducing LTP, is that each is
critically reliant on activation ofNMDA receptors during the period of conditioning
stimulation. However, our experiments suggest that galanin does not (1) inhibit
glutamate release per se, as suggested in one neurochemical study (Zini et al., 1993).
or (2) directly antagonize NMDA receptors triggering the induction ofLTP by both
stimulation protocols (Collingridge et al., 1983; Davies et al., 1991). In addition,
whilst antagonism of metabotropic glutamate receptors during both stimulation
paradigms leads to the generation of prolonged STP (similar to that observed when
galanin is applied during the period of conditioning stimulation) as opposed to
maintained LTP, (Bashir et al., 1993; Breakwell et al., 1996) galanin did not appear
to act as an antagonist of mGluR Group I function, that may be involved in
modulating LTP in the CA1 area via the activation of PLC, which is thought to be
the coupling mechanism of GALR2 (Fathi et al., 1997; Wittau et al., 2000)
Given the complexity of LTP and the varied effects of galanin in the CNS (e.g.,
inhibition of transmitter release, inhibition of adenylate cyclase (Rokeaus, 1987;
Kask et al., 1995), it is possible to devise many alternative mechanisms that account
for its effect on LTP. For example, galanin may inhibit the intracellular calcium rise
that is responsible for triggering changes in intracellular biochemistry that maintain
LTP. In this respect, whilst galanin can inhibit intracellular calcium rises through
inhibition of voltage-gated calcium currents (Palazzi et al., 1991) these channels
have little bearing on the induction of LTP although they have been reported to
influence the induction ofLTD (Wang et al., 1997a-c). Furthermore, based on our
own observations that galanin inhibited LTP without affecting LTD, it seems
unlikely that galanin is exerting its inhibitory effect through this mechanism.
Beyond the levels of receptor and intracellular calcium rises, there is a strong
consensus that kinase activity is responsible for the conversion of STP into LTP,
although the precise sequence of this multi-kinase biochemical cascade has yet to be
precisely defined (Malinow et al., 1989; Bliss & Collingridge, 1993; Grant &
O'Dell, 1994). Thus, it is conceivable that galanin may restrict the induction of LTP
by disturbing this biochemical cascade. Indeed, four lines of evidence reported here,
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when taken together, suggest that this may be the case. These are (1) the time points
of application ofgalanin that are effective at inhibiting LTP mirror those for many
kinase inhibitors (Malinow etal., 1989; Bliss & Collingridge, 1993; Grant & O'Dell,
1994; Zhuo et al., 1995) (2) the time course of STP induced in the presence of
galanin is similar to that observed for many kinase inhibitors (Malinow et al., 1989;
Bliss & Collingridge, 1993; Grant & O'Dell, 1994), (3) galanin does not affect long-
term synaptic plasticity (LTD) that predominantly depends upon phosphatase, as
opposed to kinase activity (Bear & Malenka, 1994) and (4) galanin inhibits synaptic
potentiation induced by phorbol esters. Furthermore, galanin (a) restricts protein
kinase C-induced protein phosphorylation in the hippocampus (LaPorta etal., 1992)
and (b) inhibits adenylate cyclase activity (Kask et al., 1995a-b) potentially reducing
protein kinase A activity; both ofwhich may selectively restrict LTP expression.
Whatever the mechanism involved, this inhibitory effect of galanin does provide a
synaptic correlate for the galanin-induced learning impairments that have been
reported in behavioural tests such as the Morris water maze task, delayed non-
matching to sample and active avoidance tests (Crawley & Wenk, 1989; Crawley,
1993). It should be pointed out, however, that this is unlikely to be the only
mechanism contributing to the galanin-induced impairment of learning since galanin
can inhibit septohippocampal cholinergic inputs (Fisone et al., 198; Dutar et al.,
1995; Palazzi et al., 1991), which have a major impact on these learning paradigms.
Whilst this may have an negative effect on learning in its own right, in terms of LTP
this effect will be most evident on associative LTP in which cholinergic and
glutamatergic afferents are activated coincidentally (Sokolov et al., 1995). This,
however, is unlikely to explain the in vitro results presented here where non-
associative LTP was examined and which is independent of either muscarinic or
nicotinic acetylcholine receptor stimulation. If the galanin mutation does not affect
glutamate or GABAergic synaptic transmission in rats and mice that would indicate
that the galanin-null knockout mouse exhibits selective modification of the
cholinergic system (O'Meara et al., 2000).
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4.4. Future Experiments
I was unable to determine the site of action of galanin from my recordings. However,
it would be useful to determine whether galanin acts at a pre- or a postsynaptic site to
exert its degradatory effect on synaptic plasticity in the CA1 area of rodent
hippocampus. Furthermore, as already mentioned earlier in this chapter, galantide is
not a very specific antagonist to galanin receptors. Further pharmacological
characterisation of galanin receptor mediated physiology hippocampal slices awaits
the development of galanin receptor subtype specific agonists and antagonists. In
vitro experiments are difficult to perform due to the instability of peptide analogues
throughout the duration of an experiment. Therefore, non-peptide compounds active
on galanin receptors would be favoured, e.g. SCH202596. Finally, new insights into
the physiology of galanin and galanin sensitive receptors in the cortex would be shed
with a conditional receptor knockout or overexpression animal model rather than a
global galanin-null knockout mouse. It remains to be investigated how exogenous
galanin affects GABAergic transmission proper in the CA1 area of rodent




SYNAPTIC PLASTICITY AND TRANSMISSION IN GALANIN-
NULL TRANSGENIC MICE AND WILD-TYPE LITTERMATES
5.1. Introduction
Here, I show that although basal synaptic transmission and short-term synaptic
plasticity is not affected by the galanin-null mutation (Figures from 5.1 to 5.6),
tetanus-induced LTP is significantly impaired in stratum oriens, but not radiatum in
slices obtained from Gal"7" mice (Figures 5.7 and 5.9). This is impairment is not age-
dependent, but appears to depend on the conditioning stimulus, as it does not occur
during LTP induced by theta-burst (Figure 5.8). Additionally, synaptic plasticity
exhibits a significant impairment following a saturation paradigm as well, which is
confined to recordings performed in stratum oriens only (Figure 5.10). Finally,
exogenous galanin perfusion causes an impairment in tetanus induced LTP and
inhibits the cholinergic EPSPm in wild-type mice, but not in the Gal"" mice (Figures
5.11 and 5.12). All the results in this chapter were obtained by myself, apart from the
intracellular EPSPm data, which were obtained in conjunction with Dr. I. R. Kearns.
5.2. Results
5.2.1. Global galanin gene deletion does not affect synaptic strength
Synaptic strength of glutamatergic synaptic transmission may be assessed by
mapping the size of fEPSPs to the intensity of stimulation used (Skelton et al., 1983).
I recorded fEPSPs evoked in response to electrical stimulation. Two groups of mice
were used (1) young (3-5 months) and (2) old (11-13 months) and for each age group
synaptic transmission was assessed in two areas of the CA1, stratum radiatum and
stratum oriens. The slope of fEPSPs was measured over a range of stimulus
intensities from 0 to 80V. There was no significant difference observed in stratum
radiatum of young (wild-type, Gal"7"; n=7,7) or old (wild-type, Gal"; n=9,12) mouse
groups. Similarly, there was no significant difference observed in stratum oriens
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Figure 5.1. Global galanin gene deletion does not affect synaptic strength. Input-output curves
featuring the normalised amplitude to percentage maximum of field EPSPs evoked in CA1 area
of the hippocampus over a range of stimulus intensities from 0 to 80 V. The experiment was
performed in both basal (wild-type Wt, transgenic Gal"'"; n=7,7) and apical (Wt, Gal"'" n=9,12)
dendrites in young (WT, Gal"'"; n=7,7) and old mice (Wt, Gal '"; n=8,6). Paired Student's t-test
revealed no significant difference between wild-type (closed shapes) and transgenic (open
shapes) slices in neither group (Student's t-test, P>0.05). Each point is the pooled average of
four sweeps. The traces inside each panel depict a synaptic response obtained from a wild-type
(black traces) or a Gal"'" (red traces) mouse slice for the respective group, evoked at 40V.
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young (wild-type, Gal""; n=7,7) or old (wild-type, Gal"7"; n=8,6) mice. Statistical
significance was assessed using Student's t-test, P<0.05. See Figure 5.1.
5.2.2. Lack of galanin does not affect short-term synaptic plasticity
I used paired pulse facilitation (PPF) as a marker of short-term synaptic plasticity in
the CA1 area of the hippocampus. PPF was examined by delivering two consecutive
shocks across a range of interpulse intervals between 12.5 and 400 ms. Short-term
synaptic plasticity was assessed by measuring the ratio of the initial slope of the
ffiPSP in response to the second stimulus over that of the field in response to the first
stimulus. The pooled average ratios from means of four sweeps for each interpulse
interval were plotted against the intervals (Figure 5.2.). In the young group of
animals tested in both stratum radiatum (wild-type, Gal""; n=6,8) and stratum oriens
(wild-type, Gal"7"; n=9,7) there was no significant difference between transgenic and
wild-type littermates. Similarly, in the old group of animals tested in stratum
radiatum (wild-type, Gal"7"; n=7,7) there was no significant difference at all
interpulse intervals tested. During recordings in stratum oriens, however, there was a
statistical significance when the two pulses were delivered 100 and 200 ms apart.
Statistical difference was assessed using Student's t-test (P<0.05). Figures 5.3 to 5.6
illustrate superimposed traces of individual recordings underoing a paired-pulse
facilitation protocol.
5.2.3. The effect of galanin-null mutation on LTP
How does the absence of galanin from birth affect LTP in the CA1 area of mouse
slices? This series of experiments is illustrated in Figures 5.7 to 5.9. In panels 5.7A,
5.8A and 5.9/1 superimposed traces of baseline and post-conditioning stimulation
fEPSPs are shown corresponding to individual recordings laid out immediately
below.
Similarly to the way LTP experiments were performed as described in Chapter 4,
tetanic or theta-burst stimulation was delivered after a 20-minute baseline was
obtained. LTP was assessed for at least 60 minutes following the conditioning
stimulation in the CA1 area of slices obtained from either young or old mice. As
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shown in Figure 5.IB (bottom panel), tetanus-induced LTP was significantly
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Figure 5.2. Global galanin gene deletion does not significantly alter PPF ratios. PPF experiments
were carried out by two simultaneous shocks of identical strength at interpulse intervals
between 12.5 and 400 ms, so that the magnitude of the evoked field EPSP slope in response to
the first shock (SI) is half maximal. Each point in the above graphs constitutes the PPF ratio,
equal to S2/S1, where S2 is the initial slope of fEPSPs in response to the second stimulus and is
the pooled average of four consecutive sweeps. Paired Student's t-test revealed no significant
difference (P<0.05) between wild-type (filled circles) and transgenic (open circles) slices when
the experiment was performed in stratum radiatum in young mice (Wt, Gal'; n=6,6) and in old








Figure 5.3. Superimposed traces illustrating a paired-pulsed facilitation recording in stratum









Figure 5.4. Superimposed traces illustrating a paired-pulsed facilitation recording in stratum
oriens of young wild-type (A) and Gal' mice (B) at interpulse intervals between 25 and 400 ms.
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B
Figure 5.5. Superimposed traces illustrating a paired-pulsed facilitation recording in stratum








Figure 5.6. Superimposed traces illustrating a paired-pulsed facilitation recording in stratum oriens
of old wild-type (A) and Gal7 mice (B) at interpulse intervals between 25 and 400 ms.
wild-type (n=8) to 134 + 8 % S.E.M. in slices prepared from transgenic mice (n=8).
However, in stratum radiatum the values as measured 30 minutes post-tetanus were
152 ± 9 % S.E.M. for wild-type (n=8) and 149 ± 8 % S.E.M. for transgenic mice
(n=8). Figure 5.9B illustrates that the magnitude of LTP impairment was increased in
recordings performed in stratum oriens of old mouse slices from 145 + 11% S.E.M.
(wild-type, n=6) to 119 ± 9 % S.E.M. (Gal"7", n=9), while LTP in stratum radiatum
was indistinguishable between wild-type (155 ± 6 % S.E.M., n=8) and Gal"7" mice
(150 ± 5 % S.E.M., n=8). Theta-burst induced LTP was indistinguishable between
genotypes, in both stratum oriens (150 ± 5 % S.E.M., 151 ± 4 % S.E.M. for wild-
type, Gal"7"; n=8,8) and radiatum (140 ± 5 % S.E.M., 139 ± 4 % S.E.M. for wild-
type, Gal"7"; n=8,8) in slices obtained from young mice, as shown in Figure 5.8A.
5.2.4. Why does galanin deletion impair LTP in stratum oriens?
The final experiment was designed to address the reasons why the absence ofgalanin
caused a significant impairment in LTP restricted to recordings performed in stratum
oriens in the old animals. One possibility could be that the aforementioned genetic
manipulation caused a faster saturation of synaptic plasticity in that area. Therefore,
we designed a saturation protocol in which LTP was induced by a series of 100Hz,
Is tetani and each tetanus separated from the previous one by 30 minutes. This was
repeated as many times as required to induce saturation ofLTP. Saturation was
defined as no further potentiation of the initial slope of fEPSPs following a tetanus.
For most slices saturation occurred following the fifth tetanus and then stimulus
intensity was turned down to obtain pre-LTP baseline sized fEPSPs. Again a baseline
was recorded for twenty minutes before a further final tetanisation was delivered.
This was used as a check that saturation of glutamate receptor mediated synaptic
plasticity had actually occurred. Figure 5.10 shows pooled data in graphical format
of recordings from both stratum radiatum and oriens in young and old animals. As
expected saturation occurred to a singificantly greater extent in slices obtained from




Figure 5.7. Tetanus mediated LTP is significantly impaired in stratum oriens of young
transgenic mice. LTP experiments were performed as described in Figure 4.1. In A,
superimposed traces denote control and 30 minutes post-tetanus synaptic response from wild-
type (left panels) and Gal ' mice (right panels). In B, individual experiments illustrate LTP in
stratum radiatum (top left panel) or oriens (top right panel) in slices prepared from wild-type
(filled circles) or Gal ' (open circles) mice. Pooled data from young mice are shown in graphical
representation, where tetanus induced LTP is indistinguishable between wild-type (filled circles)
and Gal"'" mice (open circles) in stratum radiatum (bottom left panel), but significantly impaired
in stratum oriens of Gal"' mice (bottom right panel). Statistical significance was assessed by
Student's t-test and ANOVA, P>0.05.
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Figure 5.8. Theta-burst mediated LTP is indistinguishable between genotypes in the CA1 area
of young transgenic mice. LTP experiments were performed as described in Figure 4.1. In A,
superimposed traces denote control (black traces) and 30 minutes following theta-burst synaptic
responses (red traces) from wild-type (left panels) and Gal"7" mice (right panels). In B,
individual experiments illustrate LTP in stratum radiatum (top left panel) or oriens (top right
panel) in slices prepared from wild-type (filled circles) or Gal"7" (open circles) mice. Pooled data
from young mice are shown in graphical representation, where LTP induced by theta-burst is
indistinguishable between wild-type (filled circles) and Gal"7" mice (open circles) in stratum
radiatum (bottom left panel) or oriens (bottom right panel). Statistical significance was assessed
by Student's t-test and ANOVA, P>0.05.
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Figure 5.9. Tetanus mediated LTP is significantly impaired in stratum oriens of old transgenic
mice. LTP experiments were performed as described in Figure 4.1. In A, superimposed traces
denote control and 30 minutes post-tetanus synaptic response from wild-type (left panels) and
Galv" mice (right panels). In B, individual experiments illustrate LTP in stratum radiatum (top
left panel) or oriens (top right panel) in slices prepared from wild-type (filled circles) or Gal"7"
(open circles) mice. Pooled data from young mice are shown in graphical representation, where
tetanus induced LTP is indistinguishable between wild-type (filled circles) and Gal 7" mice (open
circles) in stratum radiatum (bottom left panel), but significantly impaired in stratum oriens of
Gal 7 mice (bottom right panel). Statistical significance was assessed by Student's t-test and
ANOVA, P>0.05.
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Figure 5.10. Saturation of LTP was tested by repeated tetanic stimulation (100Hz, Is) every 30
minutes before the next tetanisation. The procedure was reapeated 5 times until synapses did
not potentiate any further. Breaks indicate subsequent reduction (LFS, 0.067Hz) so that fEPSP
slope was of similar magnitude to baseline values and a new baseline was recorded for 20
minutes before delivery of a final tetanus. The experiment was performed for wild-type and
transgenic mouse slices and pooled data are presented in bar charts showing percentage of
normalised fEPSP slope 20 minutes following each tetanus for wild-type (grey bars) and
transgenic (black bars) slices. Statistical significance is indicated by * Student's t-test, ANOVA,
P<0.05. Values are represented as ± S.E.M.
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5.2.5. Exogenous galanin causes LTP impairment only in wild-type mouse slices
Exogenous galanin at a concentration of lOOnM was perfused to assess its effects on
LTP in both wild-type or Gal7" mouse slices. Pooled data are illustrated in Figure
5.11. It is noteworthy that galanin did impair LTP induced by 100Hz for Is
significantly in wild-type animals, but did not have any effect on Gal7" mouse slices.
To investigate whether lack of endogenous galanin has any effect on hippocampal
synaptic plasticity experiments described in Chapter 4, were repeated in galanin-null
mouse slices. As such, lOOnM galanin reduced the magnitude of LTP induced by a
100 Hz for 1 s tetanus delivered in both stratum radiatum and oriens. The
magnitudes ofLTP measured 30 minutes post-tetanus in the presence and absence of
galanin in stratum radiatum were 146.9 ± 9.6 % (n = 7) and 149.6 ± 11.6 % SEM (n
= 10) (ANOVA, P<0.05) and in stratum oriens 137.8 ± 8.7 % (n = 8) and 135.8 ± 8.7
% SEM (n = 6) (ANOVA, P<0.05). The averaged normalised values were 145.5 ±
12.2 % & 135.2±10 % SEM {stratum radiatum) for control and 144.7 ± 9.6 % &
143.1 ± 14.5 % SEM {stratum oriens) for galanin-treated slices (Student's t-test,
P<0.05) compared to average baseline values 100.1+3 % and 98.2+4.8 % SEM and
99.27+2.2 % SEM, respectively.
5.2.6. Lack of galanin compromises cholinergic EPSPm in the CA1 area
The last series of experiments was designed to test the effect of the absence of
galanin on cholinergic transmission in the hippocampus assessed by the muscarinic
acetylcholine receptor mediated field EPSP (EPSPm)-
Electrical stimulation of stratum oriens of mouse hippocampal slices produced in
CA1 pyramidal cells a muscarinic acetylcholine receptor mediated slow
depolarisation which appeared very similar to the EPSPm recorded from rat
hippocampal neurones (Nicoll & Cole, 1983; Dutar et al., 1987). Figure 4.5. Both
wild-type (n=4) and Gal7" (n=4) mice demonstrated EPSPms. On application of
400nM exogenous galanin, the peak amplitude of EPSPm was inhibited by 50+3% of
control in wild-type mice (n=4; p<0.05). In contrast, 400nM galanin had no
significant effect on the peak amplitude of the EPSPm in Gat'' mice (94+5% of
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control, n=4; p>0.05). This significant difference was observed in the magnitude of
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Figure 5.11. Exogenous Galanin fails to affect LTP in galanin null mice. Galanin caused an
impairment in LTP induced in slices prepared from young mice. Galanin (100 nM) was
perfused for 20 mins before and was terminated 15 mins after high frequency stimulation. A,
LTP induced in in slices prepared from wild-type animals was diminished in the presence of
gaianin but unaffected in slices from galanin-null transgenic animals (naive filled circles; Wt,
Ko n=12,H) and (galanin-treated open circles; Wt, Ko n=7,7). B, The same experiment was
repeated in stratum oriens (Wt, Ko n=8,8) and (Wt, Ko n=7,7). Statistical significance was
assessed by Student's t-test at t=30 mins following HFS, P<0.05 (top graphs) and P>0.05 (bottom
graphs).
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Figure 5.12. The effect of galanin deletion on cholinergic EPSPMs. A shows synaptic traces of EPSPMs recorded
from the CA1 pyramidal cell held between -64 and -69 mV. The top traces illustrate the EPSPM from wild
type slices before (left) and after (right) the application of 500 nM rat galanin. The bottom traces show the
EPSPm from Gal ' slices before (left) and after (right) the application of galanin. The filled triangles denote the
position of the stimulus. Bar graph (B) illustrates the effect of galanin on the mean peak amplitude of the
EPSPm in wild type and Gal"'" mice in 4 and 4 experiments respectively. Values are mean + S.E.M. represented
by the error bars.
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5.4. Discussion
Here, I showed that global galanin deletion does not seem to affect basal glutamate
receptor mediated synaptic transmission or short-term synaptic plasticity in the CA1
area of the hippocampus in galanin null mice or wild-type littermates. However, the
absence of galanin appears to have a selective, progressive, degradatory effect on
glutamate receptor long-term synaptic plasticity restricted to stratum oriens from the
young to the older animals. This effect seems to stem from the lack of a background,
neuroprotective physiological role of galanin. This role may entail a greater
susceptibility to saturation of synaptic plasticity in the galanin null mouse slices
compared to wild-type littermates. The effect is progressive with age which may
reflect the fact that galanin's neuroprotective role may become increasingly more
important with age (Lamour et al., 1988; Mufson et al., 1993; White et al., 1994;
Tsutsui et al., 1994; Auchus et al., 1994; Krywlowski et al., 1993 & 1994; Ceresini
et al., 1994). The region specificity to stratum oriens is only expected since there are
more galanin sensitive receptor sites in that area and also the cholinergic projection,
from which galanin is released, terminates densely in the apical dendrites of the CA1
area (Melander et al., 1985; Fisone et al., 1987; Ogren et al., 1992 & 1998; Xu et al.,
1998; Schott etal., 1998). I, therefore, speculate that the role of galanin becomes
pivotal in that area of the hippocampus. This conclusion is in agreement with our
final finding that exogenous galanin supresses both tetanus induced LTP and the
muscarinic receptor mediated cholinergic EPSP in the CA1. This observation
provides further evidence that galanin directly affects cholinergic transmission, while
its effect on LTP may be a resulting outcome of a compromised cholinergic
excitatory neurotransmission, rather than a direct effect of glutamate receptor
mediated synaptic plasticity. As such, provides indirect evidence for the excitatory
role of cholinergic transmission in the modulation of synaptic plasticity in the CA1
area. These mice show fewer cholinergic markers in the medial septum and vertical
diagonal band of Broca and an increase in ChAt activity implying that the remaining
cholinergic neurons have compensated for the developmental loss by upregulating
ChAT activity. This is supported by the lack of behavioural deficits when mutant
mice were tested in the Morris water maze. The loss of cholinergic cells with age is a
process that has been reported in the rat. There is no further age-dependent loss of
127
cholinergic neurons in the mutant mice suggesting that the cholinergic neurons lost
with age are the same subset of neurons that are lost due to the galanin gene
knockout. However, a decrease of Ach release was observed in aged mutant mice,
paralleled by significant deficits in performance in the Morris water maze. Also, in
this chapter, a study of the effect of bath applied galanin on cholinergic
neurotransmission was completed in the stratum oriens of rat slices as well as slices
taken from wild-type and galanin deficient mice.
It appears that the galanin mutation does not affect glutamate synaptic transmission
indicating that this knockout mouse exhibits selective modification of the cholinergic
system (O'Meara et al., 2000; Coumis and Davies, 2002). Therefore, it is unlikely
that this mutation is causing any major reorganisation of neuronal circuits as tyrosine
kinase knockouts do for example (Grant & Silva, 1994).
5.5. Future Experiments
The use of galanin antagonists to investigate their effects on synaptic transmission
and plasticity in the CA1 area would be a useful method of confirming whether
endogenous galanin is tonically released to modulate amino acid and cholinergic
neurotransmission in the hippocampus. The most likely explanation ofwhy tetanus
induced LTP is significantly impaired in the old animals is that the theta-burst
stimulation paradigm was subthreshold for the expression of that impairment. It
would be of interest to investigate whether LTP induced by a variety of stimulation




In this thesis, prior knowledge of the molecular mechanisms of synaptic transmission
and plasticity in the CA1 area of the hippocampus is rodents and the methods of
investigating those, were utilised to study in vitro hippocampal function in rats and
galanin-null mice with a view to determining the physiological role of galanin.
In Chapter 3,1 showed that galanin causes a dose-dependent increase in the slope of
fEPSPs which is dependent on the hippocampal slice being intact. In CA3 ectomised
slices, galanin does not have any effect on neither the slope of the fEPSPs nor PPF.
However, at high concentrations galanin also significantly reduced PPF in the intact
slice. I conclude that galanin may act on presynaptic receptors to enhance
presynaptic excitability and that this effect is abolished when the presynaptic input to
the CA1 area coming from the CA3 area is cut.
In chapter 4,1 attempted to investigate the role of exogenously applied galanin on
synaptic transmission and plasticity in the CA1 area in rats. In brief, my results show
that galanin, by itself, causes a dose-dependent impairment in LTP induced by
traditional high frequency stimulation protocols. This action does not appear to
interfere with NMDA, AMPA, GABA or mGlu receptor function, but is probably
mediated by distinct galanin receptor sites and is possible the combined effect of a
multiple type of galanin sensitive receptors and appears to be reversible by the
known galanin antagonist Ml5.. My data suggest, but do not conclusively prove, that
the galanin-induced LTP impairment may be mediated via a PKC dependent
intracellular pathway. Galanin does not seem to affect LTD in the CA1 area.
(Coumis & Davies, 2002).
The research study described in Chapter 5, involved galanin-null mice and wild-type
littermates. The results indicate an age-dependent, progressive impairment in long-
term synaptic plasticity, which appears to be specific to stratum oriens. This does not
appear to be accompanied by any significant difference between wild-types and
transgenic mice in the strength of fEPSPs or short-term plasticity, assessed by paired-
pulse facilitation. My data support histological studies, which corroborate cholinergic
loss in markers and neurotransmitter in the septocholinergic pathway projecting from
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MS to the hippocampus and denotes the importance of that pathway to its densest
projection in stratum oriens (Nyakas et al., 1987; Biasco-Ibanez & Freund, 1995;
Morton & Davies, 1997; Xu et al., 1998;0'Meara et al., 2000). My data correlate
nicely with behavioural impairment in the standard Morris watermaze task and
further confirm the role of galanin as a neuroprotective agent in neuropathological
conditions. The lack of galanin seems to cause deterioration of saturarability in
synaptic transmission evident in both stratum oriens and radiatum (O'Meara et al.,
2000). However, more detailed in vitro studies should be done in conditional, time
specific knockout model rather than a mouse strain subjected to global galanin gene
deletion. This would achieve the precise delineation of the role of galanin in the
hippocampus and would allow correlations to be made with standard models of
neurodegerative disease. As such, the galanin-null mouse strain, although it
resembles ageing phenotype in disease it fails both to ascribe a specific function to
galanin and to resemble any of the hallmarks of a well-defined disease condition.
Chapters 4 and 5, in combination, point towards a possible role for galanin largely
modulating glutamatergic and/or cholinergic transmission in that area, probably by
restricting it during high frequency stimulation, thereby causing a deterioration in
glutamate receptor mediated long-term synaptic plasticity in vivo. This action may be
neuroprotective during pathological conditions. Galanin receptor conditional
knockouts and specific galanin receptor subtype drugs will prove useful in
determining which receptor is responsible for which effect.
On the whole, the work presented in this thesis is the result of a contemporary trend
in biomedical research incorporating the study of transgenic animals at different
levels, thereby contributing to a hollistic view of the biology of the hippocampus in
health and disease. That would facilitate the discovery and development of
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